{"content":"<li class=\"n-box-item date-title\" data-end=\"1536292799\" data-start=\"1536206400\" data-txt=\"Monday, December 23, 2019\">Thursday, September  6, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3388593\" data-ts=\"1536273022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388593-marvell-techplus-7-after-hiking-estimates-for-cavium-cost-savings-revenue-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvell Tech +7% after hiking estimates for Cavium cost savings, revenue gains</a></h4><ul>     <li>Marvell Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) adds to <a href=\"https://seekingalpha.com/news/3388548-marvell-plus-1_2-percent-first-earnings-since-cavium-acquisition\" target=\"_blank\">initial post-earnings gains</a>, <font color='green'>+7%</font> after disclosing <a href=\"https://www.marketwatch.com/story/marvell-stock-jumps-after-new-details-on-cavium-merger-shared-2018-09-06\" target=\"_blank\">higher estimates for cost savings</a> and saying the Cavium addition would help it hit forecast revenue gains.</li>     <li>\"I'm very confident that our combined team will drive us towards our long term 6%-8% annual revenue growth target,\" CEO Matt Murphy said in the earnings conference call, adding that cost synergies previously guided at $150M-$175M/year actually would reach $200M/year by the end of FY 2020.</li>     <li>MRVL issues guidance for Q3 EPS of $0.30-$0.34, revenues of $825M-$865M, non-GAAP gross margin 64%-65%, non-GAAP operating expenses $300M-$305M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388593\" data-linked=\"Marvell Tech +7% after hiking estimates for Cavium cost savings, revenue gains\" data-tweet=\"$MRVL - Marvell Tech +7% after hiking estimates for Cavium cost savings, revenue gains https://seekingalpha.com/news/3388593-marvell-techplus-7-after-hiking-estimates-for-cavium-cost-savings-revenue-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3388593-marvell-techplus-7-after-hiking-estimates-for-cavium-cost-savings-revenue-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388591\" data-ts=\"1536271571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388591-ocular-therapeutixplus-3_1-piper-looks-to-dextenza-ok\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocular Therapeutix +3.1% as Piper looks to Dextenza OK</a></h4><ul>   <li>In a note, Piper Jaffray foresees FDA approval for Ocular Therapeutix's Dextenza by the end of year, and initiated coverage of the stock at Overweight.</li>    <li><a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> is <font color='green'>up 3.1%</font> after hours.</li>    <li>Analyst Joseph Catanzaro says previous issues from response letters have been sufficiently addressed to proceed to approval, and that a favorable label and reimbursement environment will drive U.S. sales in the post-surgical setting over $250M by 2025. (h/t Bloomberg)</li>    <li>The firm has a $14 price target, implying 109% upside from today's close of $6.69.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388591\" data-linked=\"Ocular Therapeutix +3.1% as Piper looks to Dextenza OK\" data-tweet=\"$OCUL - Ocular Therapeutix +3.1% as Piper looks to Dextenza OK https://seekingalpha.com/news/3388591-ocular-therapeutixplus-3_1-piper-looks-to-dextenza-ok?source=tweet\" data-url=\"https://seekingalpha.com/news/3388591-ocular-therapeutixplus-3_1-piper-looks-to-dextenza-ok\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388586\" data-ts=\"1536270449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388586-after-hours-gainers-losers-09-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (09/06/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a> <font color='green'>+15.3%</font>. <a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='green'>+9.2%</font>. <a href='https://seekingalpha.com/symbol/NX' title='Quanex Building Products Corporation'>NX</a> <font color='green'>+9.1%</font>. <a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color='green'>+8.3%</font>. <a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='green'>+7.4%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='red'>-6.2%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/ERF' title='Enerplus Corporation'>ERF</a> <font color='red'>-3.4%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color='red'>-2.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388586\" data-linked=\"After Hours Gainers / Losers (09/06/2018)\" data-tweet=\"$OKTA $OKTA $MRVL - After Hours Gainers / Losers (09/06/2018) https://seekingalpha.com/news/3388586-after-hours-gainers-losers-09-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3388586-after-hours-gainers-losers-09-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388582\" data-ts=\"1536269631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOME\" target=\"_blank\">HOME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388582-homeminus-1_6-selling-stockholders-offer-10m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">At Home -1.6% as selling stockholders offer 10M shares</a></h4><ul>   <li>At Home Group (NASDAQ:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a>) is <font color='red'>1.6% lower</font> after hours following the company's filing disclosing that shareholders are <a href=\"https://seekingalpha.com/filing/4162692\" target=\"_blank\">offering 10M shares for sale</a>.</li>    <li>The company won't receive proceeds from the sales.</li>    <li>Selling stockholders are AEA, a 25.1% holder with 15.945M shares, and Starr Investments, which holds a stake of 21.3% (and 13.538M shares).</li>    <li>Assuming full exercise of an underwriter's option, AEA will sell just under 6.22M shares (leaving it with a 15.3% stake), and Starr will sell just over 5.28M shares (leaving it with 13.01% of the company).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388582\" data-linked=\"At Home -1.6% as selling stockholders offer 10M shares\" data-tweet=\"$HOME - At Home -1.6% as selling stockholders offer 10M shares https://seekingalpha.com/news/3388582-homeminus-1_6-selling-stockholders-offer-10m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3388582-homeminus-1_6-selling-stockholders-offer-10m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388567\" data-ts=\"1536267348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388567-oktaplus-16-on-q2-beats-upside-q3-and-fy-guides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Okta +16% on Q2 beats, upside Q3 and FY guides</a></h4><ul>     <li>Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>)&nbsp;<font color='green'>soars 16.3%</font>&nbsp;aftermarket on Q2 results that beat EPS and revenue estimates with a 57% Y/Y revenue growth. Upside Q3 guidance has revenue from $96M to $97M (consensus: $88.96M) and EPS of -$0.12 to -$0.11 (consensus: -$0.17).</li>     <li>Upside FY19 guidance has revenue from $372M to $375M (consensus: $356.5M) and EPS of -$0.48 to -$0.46 (consensus: -$0.56).</li>     <li>Revenue breakdown: Subscription, $87.9M (consensus: $78.3M); Professional Services, (consensus: $6.4M).</li>     <li>Earnings call starts at 5 PM Eastern with a webcast available <a href=\"https://seekingalpha.com/pr/17263559-okta-announces-record-second-quarter-fiscal-2019-financial-results\" target=\"_blank\">here</a>.</li>     <li><a href=\"http://investor.okta.com/\" target=\"_blank\">Press release</a>.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3388518-okta-beats-0_04-beats-revenue\" target=\"_blank\">Okta beats by $0.04, beats on revenue</a> (Sept. 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388567\" data-linked=\"Okta +16% on Q2 beats, upside Q3 and FY guides\" data-tweet=\"$OKTA - Okta +16% on Q2 beats, upside Q3 and FY guides https://seekingalpha.com/news/3388567-oktaplus-16-on-q2-beats-upside-q3-and-fy-guides?source=tweet\" data-url=\"https://seekingalpha.com/news/3388567-oktaplus-16-on-q2-beats-upside-q3-and-fy-guides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388563\" data-ts=\"1536266886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYTU\" target=\"_blank\">AYTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388563-aytu-bioscience-reports-fy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AYTU BIOSCIENCE reports FY results</a></h4><ul><li>AYTU BIOSCIENCE (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>): FY GAAP EPS of -$15.31.</li><li>Revenue of $3.66M (+13.7% Y/Y)</li><li>Shares <font color='green'>+13.75%</font>.</li><li><a href='https://seekingalpha.com/filing/4162729'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388563\" data-linked=\"AYTU BIOSCIENCE reports FY results\" data-tweet=\"$AYTU - AYTU BIOSCIENCE reports FY results https://seekingalpha.com/news/3388563-aytu-bioscience-reports-fy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3388563-aytu-bioscience-reports-fy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388558\" data-ts=\"1536266634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388558-palo-alto-networksplus-3_5-on-q4-beats-and-upside-q1-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks +3.5% on Q4 beats and upside Q1 guide</a></h4><ul><li>        Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>)&nbsp;<font color='green'>gains 3.5%</font>&nbsp;aftermarket on Q4 results that beat EPS and revenue estimates with 29% Y/Y revenue growth. Upside Q1 guidance has revenue of $625M to $635M (consensus: $620.09M) and EPS of $1.04 to $1.06 (consensus: $1.04).</li><li>               Revenue breakdown: Product, $267.6M (consensus: $247.9M); Services, $390.5M (consensus: $386.2M).&nbsp;</li><li>               Key metrics: cash from operations, $252.5M (FS: $239.6M); ending deferred revenue, $2.36B (+33% Y/Y; FS: $2.35B); billings, $868.1M (+29% Y/Y; consensus: $825.9M).&nbsp;&nbsp;</li><li>               Earnings call started at 4:30 PM Eastern with a webcast available <a href=\"https://investors.paloaltonetworks.com/investor-relations/overview/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17263573-palo-alto-networks-reports-fiscal-fourth-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Press release</a>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388532-palo-alto-networks-beats-0_11-beats-revenue\" target=\"_blank\">Palo Alto Networks beats by $0.11, beats on revenue</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388558\" data-linked=\"Palo Alto Networks +3.5% on Q4 beats and upside Q1 guide\" data-tweet=\"$PANW - Palo Alto Networks +3.5% on Q4 beats and upside Q1 guide https://seekingalpha.com/news/3388558-palo-alto-networksplus-3_5-on-q4-beats-and-upside-q1-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3388558-palo-alto-networksplus-3_5-on-q4-beats-and-upside-q1-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388554\" data-ts=\"1536266350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388554-broadcomplus-3_5-revenues-profits-grow-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom +3.5% as revenues, profits grow again</a></h4><ul>   <li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) has <font color='green'>gained 3.5%</font> in the after-hours session following a solid profit beat in its <a href=\"https://seekingalpha.com/news/3388543-broadcom-beats-0_16-misses-revenue\" target=\"_blank\">Q3 earnings</a> where revenues grew by double digits Y/Y and ticked up sequentially.</li>    <li>Gross margin rose again, to 67.3% (vs. last year's 63.3% and last quarter's 66.6%).</li>    <li>Operating income rose to $2.54B from a year-ago $2.06B, and net income from continuing operations hit $2.257B, up from last year's $1.87B and last quarter's $2.24B.</li>    <li>Free cash flow hit $2.127B for the quarter.</li>    <li>\"Datacenter demand is driving strong growth in more than 50 percent of our consolidated revenue,\" says CEO Hock Tan. \"Through the strength of our franchise business model, we delivered another quarter of sustained revenues and strong free cash flows.\"</li>    <li>Revenue by segment: Wired infrastructure, $2.3B (up 4%); Wireless communications, $1.288B (flat); Enterprise storage, $1.253B (up 70%); Industrial and other, $225M (down 5%).</li>    <li>For Q4, it's guiding to revenue of $5.325B-$5.475B (vs. consensus of $5.36B), gross margin of 66-68%, and operating expenses of $874M.</li>    <li><a href=\"https://edge.media-server.com/m6/p/myqyay4p\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17263582-broadcom-inc-announces-third-quarter-fiscal-year-2018-financial-results-quarterly-dividend\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3388554\" data-linked=\"Broadcom +3.5% as revenues, profits grow again\" data-tweet=\"$AVGO - Broadcom +3.5% as revenues, profits grow again https://seekingalpha.com/news/3388554-broadcomplus-3_5-revenues-profits-grow-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3388554-broadcomplus-3_5-revenues-profits-grow-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388553\" data-ts=\"1536266333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388553-akcea-to-axe-10-of-workforce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akcea to axe 10% of workforce</a></h4><ul><li>Ionis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>) affiliate Akcea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics'>AKCA</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1662524/000114036118037945/form8k.htm\" target=\"_blank\">discloses</a> that it intends to cut 10% of its workforce as part of its reorganization plan following the FDA's rejection of its WAYLIVRA ( volanesorsen) marketing application. It expects to record a charge of $2.0M - 2.5M this quarter to account for related expenses.</li><li>Shares are up&nbsp;<font color='green'>1%&nbsp;</font>after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3385966-fda-rejects-ionis-pharma-akceas-volanesorsen-fcs\" target=\"_blank\">FDA rejects Ionis Pharma and Akcea's volanesorsen for FCS</a> (Aug. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388553\" data-linked=\"Akcea to axe 10% of workforce\" data-tweet=\"$IONS $IONS $AKCA - Akcea to axe 10% of workforce https://seekingalpha.com/news/3388553-akcea-to-axe-10-of-workforce?source=tweet\" data-url=\"https://seekingalpha.com/news/3388553-akcea-to-axe-10-of-workforce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388548\" data-ts=\"1536265849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388548-marvellplus-1_2-on-first-earnings-since-cavium-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvell +1.2% on first earnings since Cavium acquisition</a></h4><ul><li>        Marvell Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>)&nbsp;<font color='green'>gains 1.2%</font>&nbsp;aftermarket on Q2 earnings, the first report since the Cavium buy. Q3 guidance has revenue of $825M to $865M and EPS of $0.30 to $0.34.</li><li>               Marvell completed its acquisition of Cavium about four weeks before the end of Q2 and the results include Cavium&rsquo;s from the acquisition date.&nbsp;</li><li>               Key metrics (combined, non-GAAP): Net revenue, $665.3M; gross margin, 63.7%; net income, $16@M.&nbsp;</li><li>               Earnings call is scheduled for 4:45 PM Eastern with a webcast available <a href=\"http://investor.marvell.com/phoenix.zhtml?c=120802&amp;p=irol-irhome\" target=\"_blank\">here.</a>&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17263545-marvell-technology-group-ltd-reports-second-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Press release</a>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388513-marvell-technology-group-eps-line-misses-revenue\" target=\"_blank\">Marvell Technology Group EPS in-line, misses on revenue</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388548\" data-linked=\"Marvell +1.2% on first earnings since Cavium acquisition\" data-tweet=\"$MRVL - Marvell +1.2% on first earnings since Cavium acquisition https://seekingalpha.com/news/3388548-marvellplus-1_2-on-first-earnings-since-cavium-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3388548-marvellplus-1_2-on-first-earnings-since-cavium-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388543\" data-ts=\"1536265453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388543-broadcom-beats-0_16-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom beats by $0.16, revenue in-line</a></h4><ul><li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>): Q3 Non-GAAP EPS of $4.98 beats by $0.16; GAAP EPS of $2.71.</li><li>Revenue of $5.07B (+13.2% Y/Y) in-line.</li><li>Shares <font color='green'>+3.7%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17263582-broadcom-inc-announces-third-quarter-fiscal-year-2018-financial-results-quarterly-dividend\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388543\" data-linked=\"Broadcom beats by $0.16, revenue in-line\" data-tweet=\"$AVGO - Broadcom beats by $0.16, revenue in-line https://seekingalpha.com/news/3388543-broadcom-beats-0_16-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3388543-broadcom-beats-0_16-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388536\" data-ts=\"1536265078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388536-finisarplus-7_5-after-q1-beat-healthy-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar +7.5% after Q1 beat, healthy profit guidance</a></h4><ul>   <li>Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>) has <font color='green'>jumped 7.5%</font> postmarket after topping non-GAAP profit expectations in <a href=\"https://seekingalpha.com/news/3388504-finisar-beats-0_06-beats-revenue\" target=\"_blank\">fiscal Q1 earnings</a> despite a Y/Y revenue decline, and with strong profit guidance for the current quarter.</li>    <li>Revenues did rise sequentially, to $317.3M (mainly driven by strength in wavelength selective switches) and gross margin improved over the same period due to a favorable mix.</li>    <li>Non-GAAP gross margin rose to 27.5% from last quarter's 24.7%, and operating margin climbed to 5.9% over the same period from 1.5%.</li>    <li>Expense levels came down faster than expected, CEO Michael Hurlston says, with a faster focus on product development efforts.</li>    <li>For Q2, it's guiding to revenues of $315M-$335M (vs. $333.1M consensus), non-GAAP gross margin of 28%, operating margin of 7-8%, and EPS of $0.19-$0.25 (above consensus for $0.18).</li>    <li><a href=\"http://investor.finisar.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17263513-finisar-announces-first-quarter-fiscal-2019-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3388536\" data-linked=\"Finisar +7.5% after Q1 beat, healthy profit guidance\" data-tweet=\"$FNSR - Finisar +7.5% after Q1 beat, healthy profit guidance https://seekingalpha.com/news/3388536-finisarplus-7_5-after-q1-beat-healthy-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3388536-finisarplus-7_5-after-q1-beat-healthy-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388534\" data-ts=\"1536265048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOMO\" target=\"_blank\">DOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388534-domoplus-3_6-on-q2-beats-upside-guides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Domo +3.6% on Q2 beats, upside guides</a></h4><ul><li>        Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>)&nbsp;<font color='green'>gains 3.6%</font>&nbsp;aftermarket on Q2 results that beat EPS and revenue estimates. Upside Q3 guidance has revenue of $34.8M to $35.2M (consensus: $32.88M) and EPS of -$1.39 to -$1.37 (consensus: -$1.43).</li><li>               Upside FY19 guidance has revenue of $136.7M to $137.1M (consensus: $131.38M) and EPS of -$9.55 to -$9.50 (consensus: -$9.57).&nbsp;</li><li>               Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"http://ir.domo.com/phoenix.zhtml?c=254712&amp;p=irol-IRHome\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17263514-domo-announces-fiscal-2019-second-quarter-financial-results\" target=\"_blank\">Press release</a>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388505-domo-technologies-beats-0_51-beats-revenue\" target=\"_blank\">Domo Technologies beats by $0.51, beats on revenue</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388534\" data-linked=\"Domo +3.6% on Q2 beats, upside guides\" data-tweet=\"$DOMO - Domo +3.6% on Q2 beats, upside guides https://seekingalpha.com/news/3388534-domoplus-3_6-on-q2-beats-upside-guides?source=tweet\" data-url=\"https://seekingalpha.com/news/3388534-domoplus-3_6-on-q2-beats-upside-guides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388532\" data-ts=\"1536265003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388532-palo-alto-networks-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks beats by $0.11, beats on revenue</a></h4><ul><li>Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>): Q4 Non-GAAP EPS of $1.28 <span style=\"color:green\">beats by $0.11</span>; GAAP EPS of -$0.02.</li><li>Revenue of $658.1M (+29.3% Y/Y) <font color='green'>beats by $25.05M</font>.</li><li>Shares <font color='green'>+2.3%</font>.</li><li><a href='https://seekingalpha.com/pr/17263573-palo-alto-networks-reports-fiscal-fourth-quarter-fiscal-year-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388532\" data-linked=\"Palo Alto Networks beats by $0.11, beats on revenue\" data-tweet=\"$PANW - Palo Alto Networks beats by $0.11, beats on revenue https://seekingalpha.com/news/3388532-palo-alto-networks-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3388532-palo-alto-networks-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388525\" data-ts=\"1536264868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTHR\" target=\"_blank\">CTHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388525-charles-and-amp-colvard-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charles &amp;amp; Colvard reports Q2 results</a></h4><ul><li>Charles &amp; Colvard (NASDAQ:<a href='https://seekingalpha.com/symbol/CTHR' title='Charles & Colvard Ltd'>CTHR</a>): Q2 GAAP EPS of -$0.03.</li><li>Revenue of $6.4M (-3.6% Y/Y)</li><li>Shares <font color='green'>+1.03%</font>.</li><li><a href='https://seekingalpha.com/pr/17263555-charles-and-colvard-reports-second-quarter-transition-period-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388525\" data-linked=\"Charles &amp;amp; Colvard reports Q2 results\" data-tweet=\"$CTHR - Charles &amp; Colvard reports Q2 results https://seekingalpha.com/news/3388525-charles-and-amp-colvard-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3388525-charles-and-amp-colvard-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388518\" data-ts=\"1536264675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388518-okta-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Okta beats by $0.04, beats on revenue</a></h4><ul><li>Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>): Q2 Non-GAAP EPS of -$0.15 <span style=\"color:green\">beats by $0.04</span>.</li><li>Revenue of $94.59M (+57.0% Y/Y) <font color='green'>beats by $9.77M</font>.</li><li>Shares <font color='green'>+9.57%</font>.</li><li><a href='https://seekingalpha.com/pr/17263559-okta-announces-record-second-quarter-fiscal-2019-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388518\" data-linked=\"Okta beats by $0.04, beats on revenue\" data-tweet=\"$OKTA - Okta beats by $0.04, beats on revenue https://seekingalpha.com/news/3388518-okta-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3388518-okta-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388517\" data-ts=\"1536264603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCFT\" target=\"_blank\">MCFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388517-mcbc-beats-0_15-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MCBC beats by $0.15, beats on revenue</a></h4><ul><li>MCBC (NASDAQ:<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a>): Q4 Non-GAAP EPS of $0.66 <span style=\"color:green\">beats by $0.15</span>; GAAP EPS of $0.70.</li><li>Revenue of $95.43M (+63.6% Y/Y) <font color='green'>beats by $6.13M</font>.</li><li>Shares <font color='green'>+1.14%</font>.</li><li><a href='https://seekingalpha.com/pr/17263541-mcbc-holdings-inc-reports-fiscal-2018-fourth-quarter-full-year-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388517\" data-linked=\"MCBC beats by $0.15, beats on revenue\" data-tweet=\"$MCFT - MCBC beats by $0.15, beats on revenue https://seekingalpha.com/news/3388517-mcbc-beats-0_15-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3388517-mcbc-beats-0_15-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388515\" data-ts=\"1536264541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUMZ\" target=\"_blank\">ZUMZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388515-zumiez-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zumiez beats by $0.03, misses on revenue</a></h4><ul><li>Zumiez (NASDAQ:<a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a>): Q2 GAAP EPS of $0.17 <span style=\"color:green\">beats by $0.03</span>.</li><li>Revenue of $218.97M (+13.9% Y/Y) <font color='red'>misses by $0.28M</font>.</li><li>Shares <font color='green'>+6.69%</font>.</li><li><a href='https://seekingalpha.com/pr/17263544-zumiez-inc-announces-fiscal-2018-second-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388515\" data-linked=\"Zumiez beats by $0.03, misses on revenue\" data-tweet=\"$ZUMZ - Zumiez beats by $0.03, misses on revenue https://seekingalpha.com/news/3388515-zumiez-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3388515-zumiez-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388512\" data-ts=\"1536264439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388512-five-belowplus-6-after-strong-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below +6% after strong Q2</a></h4><ul><li>Five Below (NASDAQ:<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a>) reports total sales were up 25% in <a href=\"https://seekingalpha.com/pr/17263515-five-inc-announces-second-quarter-fiscal-2018-financial-results\" target=\"_blank\">Q2</a> and comparable sales tracked 3% higher.</li><li>Operating income increased by 41.1% Y/Y to $55.1M.</li><li>Looking ahead, Five Below expects Q3 sales of $301M to $304M vs. $303M consensus off a gain of 50 stores and a 3-4% comp. Net income is anticipated to be in the range of $9.7M&nbsp;to $10.7M.</li><li>\"We believe we are well positioned to continue to execute in the second half,\" says CEO Joel Anderson.</li><li>Shares of Five Below are&nbsp;<font color='green'>up 6.02%</font>&nbsp;in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388506-five-beats-0_04-beats-revenue\" target=\"_blank\">Five Below beats by $0.04, beats on revenue</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388512\" data-linked=\"Five Below +6% after strong Q2\" data-tweet=\"$FIVE - Five Below +6% after strong Q2 https://seekingalpha.com/news/3388512-five-belowplus-6-after-strong-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3388512-five-belowplus-6-after-strong-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388507\" data-ts=\"1536264360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEAL\" target=\"_blank\">ZEAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388507-zealand-pharma-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zealand Pharma shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Zealand Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZEAL' title='Zealand Pharma'>ZEAL</a>) pending the release of news.</li><li><strong>Update</strong>: The company has <a href=\"https://seekingalpha.com/pr/17263530-zealand-sells-royalty-streams-milestones-usd-205-million-royalty-pharma\" target=\"_blank\">agreed </a>to sell future royalty streams and $85M in potential milestones for Soliqua 100/33/Suliqua and Lyxumia/Adlyxin to Royalty Pharma for $205M. It will be debt-free after redeeming the outstanding royalty bond of $24.7M.</li><li>It will remain eligible to receive up to $15M from Sanofi, expected in 2020.</li><li>Management will host a conference call tomorrow, September 7, at 9:00 am ET to discuss the transaction.</li><li>Shares will resume trading at 4:35 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388507\" data-linked=\"Zealand Pharma shares halted pending news\" data-tweet=\"$ZEAL - Zealand Pharma shares halted pending news https://seekingalpha.com/news/3388507-zealand-pharma-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3388507-zealand-pharma-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388506\" data-ts=\"1536264258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388506-five-below-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below beats by $0.04, beats on revenue</a></h4><ul><li>Five Below (NASDAQ:<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a>): Q2 Non-GAAP EPS of $0.42 <span style=\"color:green\">beats by $0.04</span>.</li><li>Revenue of $347.73M (+22.7% Y/Y) <font color='green'>beats by $12.89M</font>.</li><li>Shares <font color='green'>+4.87%</font>.</li><li><a href='https://seekingalpha.com/pr/17263515-five-inc-announces-second-quarter-fiscal-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388506\" data-linked=\"Five Below beats by $0.04, beats on revenue\" data-tweet=\"$FIVE - Five Below beats by $0.04, beats on revenue https://seekingalpha.com/news/3388506-five-below-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3388506-five-below-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388504\" data-ts=\"1536264239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388504-finisar-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar beats by $0.06, beats on revenue</a></h4><ul><li>Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>): Q1 Non-GAAP EPS of $0.18 <span style=\"color:green\">beats by $0.06</span>; GAAP EPS of -$0.16.</li><li>Revenue of $317.34M (-7.2% Y/Y) <font color='green'>beats by $1.48M</font>.</li><li>Shares <font color='green'>+6.08%</font>.</li><li><a href='https://seekingalpha.com/pr/17263513-finisar-announces-first-quarter-fiscal-2019-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388504\" data-linked=\"Finisar beats by $0.06, beats on revenue\" data-tweet=\"$FNSR - Finisar beats by $0.06, beats on revenue https://seekingalpha.com/news/3388504-finisar-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3388504-finisar-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388500\" data-ts=\"1536263478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWEN\" target=\"_blank\">BWEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388500-broadwind-energy-cuts-q3-sales-outlook-on-steel-delays-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadwind Energy cuts Q3 sales outlook on steel delays, prices</a></h4><ul><li>Boradwind Energy (<a href='https://seekingalpha.com/symbol/BWEN' title='Broadwind Energy, Inc.'>BWEN</a> <font color='red'>-3.7%</font>) slumps to within a penny of its 52-week low after <a href=\"https://www.spglobal.com/platts/en/market-insights/latest-news/metals/090618-energy-structure-manufacturer-broadwind-lowers-outlook-on-steel-delays-prices\" target=\"_blank\">lowering its Q3 sales guidance</a> by $3M-$4M to  $31M-$32M, citing slower tower production rates triggered  partially by delays in steel shipments used for fabrication.</li><li>\"The volatile steel supply situation has been extremely challenging for  us,\" says BWEN&nbsp;President and CEO&nbsp;Stephanie Kushner. \"Although tower orders are firming up for the next several quarters,  lead times for domestic steel have lengthened despite sharply higher  prices, due to the uncertainty regarding available steel imports.\"</li><li>BWEN has posted an H1 net loss from  continuing operations of $10.9M compared with profits of $5.8M in 2017, with most of the decline attributed to low  capacity utilization at its tower plants.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388500\" data-linked=\"Broadwind Energy cuts Q3 sales outlook on steel delays, prices\" data-tweet=\"$BWEN - Broadwind Energy cuts Q3 sales outlook on steel delays, prices https://seekingalpha.com/news/3388500-broadwind-energy-cuts-q3-sales-outlook-on-steel-delays-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3388500-broadwind-energy-cuts-q3-sales-outlook-on-steel-delays-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388498\" data-ts=\"1536263169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUPN\" target=\"_blank\">SUPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388498-supernus-prevails-on-appeal-of-oxtellar-xr-patents-twi-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supernus prevails on appeal of Oxtellar XR patents by TWi Pharma</a></h4><ul><li>The U.S. Court of Appeals <a href=\"https://seekingalpha.com/pr/17263479-supernus-wins-appeal-oxtellar-xr-twi\" target=\"_blank\">affirms </a>a district court decision that TWi Pharmaceuticals infringed on three patents protecting Supernus Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/SUPN' title='Supernus Pharmaceuticals, Inc.'>SUPN</a> <font color='green'>+1.7%</font>) epilepsy med Oxtellar XR. The ruling means TWi will not be able to <a href=\"https://seekingalpha.com/news/3289671-supernus-pharma-rebuffs-second-generic-challenger-oxtellar-xr\" target=\"_blank\">market its version</a> until at least 2027.</li><li>About two years ago, the appellate court found that Actavis (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-3.7%</font>) also infringed in Oxtellar XR patents.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388498\" data-linked=\"Supernus prevails on appeal of Oxtellar XR patents by TWi Pharma\" data-tweet=\"$SUPN $SUPN $TEVA - Supernus prevails on appeal of Oxtellar XR patents by TWi Pharma https://seekingalpha.com/news/3388498-supernus-prevails-on-appeal-of-oxtellar-xr-patents-twi-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3388498-supernus-prevails-on-appeal-of-oxtellar-xr-patents-twi-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388495\" data-ts=\"1536262446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSON\" target=\"_blank\">MSON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388495-misonix-fq4-revenue-miss-sinks-shares-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Misonix FQ4 revenue miss sinks shares, down 15%</a></h4><ul><li>Thinly traded micro cap Misonix (<a href='https://seekingalpha.com/symbol/MSON' title='MISONIX, Inc.'>MSON</a> <font color='red'>-14.9%</font>) is down on more than a 4x surge in volume, albeit on turnover of only 98K shares, following the <a href=\"https://seekingalpha.com/pr/17262014-misonix-reports-record-fourth-quarter-fiscal-year-2018-revenue\" target=\"_blank\">release </a>of fiscal Q4 results that featured an 8% revenue miss. The stock has sold off over&nbsp;<font color='red'>28%&nbsp;</font>since touching $21.43 on August 28.</li><li>Revenue was up 8.9% to $8.6M. Net loss widened to ($1.8M).</li></ul><div class=\"tiny-share-widget\" data-id=\"3388495\" data-linked=\"Misonix FQ4 revenue miss sinks shares, down 15%\" data-tweet=\"$MSON - Misonix FQ4 revenue miss sinks shares, down 15% https://seekingalpha.com/news/3388495-misonix-fq4-revenue-miss-sinks-shares-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3388495-misonix-fq4-revenue-miss-sinks-shares-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388490\" data-ts=\"1536261070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWN\" target=\"_blank\">SWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388490-southwesternminus-6-bmo-says-shale-sale-requires-larger-cash-flow-outspend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southwestern -6% as BMO says shale sale requires larger cash flow outspend</a></h4><ul>     <li>Southwestern Energy (<a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='red'>-6%</font>)&nbsp;sinks after BMO&nbsp;Capital <a href=\"https://thefly.com/thestreet/realmoney/index.php/SWNid2786527/SWN-Southwestern-Energy-downgraded-to-Market-Perform-at-BMO-Capital-on-asset-sale\" target=\"_blank\">downgrades</a> shares to Market Perform from Outperform with a $7 price target following <a href=\"https://seekingalpha.com/news/3387693-southwestern-minus-5-percent-shale-sale-investors-wanted-debt-reduction\" target=\"_blank\">this week's announced sale</a> of the company's Fayetteville Shale operation.</li>     <li>BMO analyst Dan McSpirit notes the sale leaves SWN as a pure play Appalachian Basin producer with a more capital-intensive business in the immediate term requiring a larger cash flow outspend and points to the still-challenging operating environment for gas producers and BMO's \"less than bullish\" view on the commodity.</li>     <li>&ldquo;We believe this cash flow-outspending outcome is consistent with the $600M in proceeds from the sale that's been set aside to supplement cash flow to develop the remaining Appalachian Basin asset,&rdquo; the analyst writes.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3388490\" data-linked=\"Southwestern -6% as BMO says shale sale requires larger cash flow outspend\" data-tweet=\"$SWN - Southwestern -6% as BMO says shale sale requires larger cash flow outspend https://seekingalpha.com/news/3388490-southwesternminus-6-bmo-says-shale-sale-requires-larger-cash-flow-outspend?source=tweet\" data-url=\"https://seekingalpha.com/news/3388490-southwesternminus-6-bmo-says-shale-sale-requires-larger-cash-flow-outspend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388484\" data-ts=\"1536260854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388484-potential-factors-in-macau-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potential factors in Macau sell-off</a></h4><ul><li>Investors puzzling over the weak performance of Macau stocks have a few items to consider.</li><li>Asia-based analysts are reporting that some leading indicators on business activity are pointing below expectations.</li><li>The Macau health bureau also issued a high alert related to dengue fever after&nbsp; several cases were in areas bordering the region.</li><li>Meanwhile, Bloomberg reports that the People&rsquo;s Bank of China and Macau&rsquo;s monetary authority signed a memorandum earlier this week to strengthen coordination in financial policies and regulation.</li><li>Adding it all up has lead to a down day for the sector and perhaps a buying opportunity for investors with the long view.</li><li>Sector watch: Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='red'>-8.8%</font>), Melco Resorts &amp; Entertainment (<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a> <font color='red'>-8%</font>), Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='red'>-2.8%</font>) and MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='red'>-1.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3388484\" data-linked=\"Potential factors in Macau sell-off\" data-tweet=\"$WYNN $WYNN $MLCO - Potential factors in Macau sell-off https://seekingalpha.com/news/3388484-potential-factors-in-macau-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3388484-potential-factors-in-macau-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388482\" data-ts=\"1536260446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388482-technology-top-5-gainers-losers-of-3_00-pm-09-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM (09/06/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a> <font color='green'>+9%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3388482\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM (09/06/2018)\" data-tweet=\"$CLDR $CLDR $INSG - Technology - Top 5 Gainers / Losers as of 3.00 PM (09/06/2018) https://seekingalpha.com/news/3388482-technology-top-5-gainers-losers-of-3_00-pm-09-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3388482-technology-top-5-gainers-losers-of-3_00-pm-09-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388480\" data-ts=\"1536259825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388480-pretium-resourcesminus-10-firm-slams-stock-says-mining-results-distorted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pretium Resources -10% as firm slams stock, says mining results distorted</a></h4><ul>     <li>Pretium Resources (<a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='red'>-9.7%</font>) plunges following a <a href=\"https://viceroyresearch.org/2018/09/06/pretium-resources-digging-up-dirt/\" target=\"_blank\">negative report</a> from Viceroy Research, which says the company's \"mining results have been distorted and the equity likely worthless as the overindebted company bleeds cash over the next 12 months.\"</li>     <li>Viceroy says the entire investment thesis for PVG rests on the validity of the 2013 bulk sample program, which it believes was manipulated \"through an  overreliance on samples taken from the Cleopatra vein, thereby artificially inflating Pretium&rsquo;s grades and reserve projections for the Brucejack Mine.\"</li>     <li>The firm says the implications of its findings on grade, tonnage and life of  mine are \"damning and lead us to believe that Pretium&rsquo;s equity is highly likely to be worthless in its current state, and its credit significantly impaired.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3388480\" data-linked=\"Pretium Resources -10% as firm slams stock, says mining results distorted\" data-tweet=\"$PVG - Pretium Resources -10% as firm slams stock, says mining results distorted https://seekingalpha.com/news/3388480-pretium-resourcesminus-10-firm-slams-stock-says-mining-results-distorted?source=tweet\" data-url=\"https://seekingalpha.com/news/3388480-pretium-resourcesminus-10-firm-slams-stock-says-mining-results-distorted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>97&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388479\" data-ts=\"1536259788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388479-tech-giants-semis-lead-1-decline-for-nasdaq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech giants, semis lead 1% decline for Nasdaq</a></h4><ul><li>Pressure from D.C. on players like Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='red'>-3.1%</font>), Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='red'>-1.9%</font>), Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-2.1%</font>), Twitter (<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a> <font color='red'>-5.6%</font>) continues to mount.</li><li>Turning to semis, they're <a href=\"https://seekingalpha.com/news/3388402-semi-stocks-slip-analysts-question-micron\" target=\"_blank\">reeling after</a> dour comments at a conference by KLA-Tencor, and some negative sell-side commentary.</li><li>The Nasdaq is<font color='red'> lower by 1%</font>&nbsp;vs. a decline of<font color='red'> just 0.35%</font>&nbsp;for the S&amp;P 500 and a&nbsp;<font color='green'>gain of 0.2%</font>&nbsp;for the Dow.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>, <a href='https://seekingalpha.com/symbol/VGT' title='Vanguard Information Technology ETF'>VGT</a>, <a href='https://seekingalpha.com/symbol/TECL' title='Direxion Technology Bull 3x Shares ETF'>TECL</a>, <a href='https://seekingalpha.com/symbol/FTEC' title='Fidelity MSCI Information Technology Index ETF'>FTEC</a>, <a href='https://seekingalpha.com/symbol/IYW' title='iShares U.S. Technology ETF'>IYW</a>, <a href='https://seekingalpha.com/symbol/ROM' title='ProShares Ultra Technology ETF'>ROM</a>, <a href='https://seekingalpha.com/symbol/QTEC' title='First Trust NASDAQ-100-Tech Index ETF'>QTEC</a>, <a href='https://seekingalpha.com/symbol/RYT' title='Invesco S&P 500 Equal Weight Technology ETF'>RYT</a>, <a href='https://seekingalpha.com/symbol/FNG' title='AdvisorShares New Tech and Media ETF'>FNG</a>, <a href='https://seekingalpha.com/symbol/TECS' title='Direxion Technology Bear 3x Shares ETF'>TECS</a>, <a href='https://seekingalpha.com/symbol/IGM' title='iShares North American Tech ETF'>IGM</a>, <a href='https://seekingalpha.com/symbol/FXL' title='First Trust Tech AlphaDEX ETF'>FXL</a>, <a href='https://seekingalpha.com/symbol/XNTK' title='SPDR NYSE Technology ETF'>XNTK</a>, <a href='https://seekingalpha.com/symbol/REW' title='ProShares UltraShort Technology ETF'>REW</a>, <a href='https://seekingalpha.com/symbol/JHMT' title='John Hancock Multifactor Technology ETF'>JHMT</a>, <a href='https://seekingalpha.com/symbol/XITK' title='SPDR Innovative Technology ETF'>XITK</a>, <a href='https://seekingalpha.com/symbol/TECZ' title='Direxion Daily Technology Bear 1x Shares ETF'>TECZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388479\" data-linked=\"Tech giants, semis lead 1% decline for Nasdaq\" data-tweet=\"$FB $FB $GOOG - Tech giants, semis lead 1% decline for Nasdaq https://seekingalpha.com/news/3388479-tech-giants-semis-lead-1-decline-for-nasdaq?source=tweet\" data-url=\"https://seekingalpha.com/news/3388479-tech-giants-semis-lead-1-decline-for-nasdaq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388477\" data-ts=\"1536259186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388477-evercore-isi-defends-wells-fargo-saying-doj-issue-isnt-new\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore ISI defends Wells Fargo, saying DoJ issue isn&#39;t new</a></h4><ul><li>Evercore ISI analyst John Pancari defends Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='red'>-1.5%</font>), saying the issue that the Department of Justice is investigating isn't new and that the bank is taking corrective actions and increasing employee training on the matter.</li><li>The probe appears to be related to employees at the bank's wholesale unit improperly altering or adding information about customers to its required \"know-your-customer\" documents.</li><li>Pancari rates Wells Fargo outperform with a price target of $63.</li><li>Source: Bloomberg First Word</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388384-wells-fargo-slips-report-wholesale-banking-unit-probe\" target=\"_blank\">Wells Fargo slips after report of wholesale banking unit probe</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388477\" data-linked=\"Evercore ISI defends Wells Fargo, saying DoJ issue isn&#39;t new\" data-tweet=\"$WFC - Evercore ISI defends Wells Fargo, saying DoJ issue isn&#39;t new https://seekingalpha.com/news/3388477-evercore-isi-defends-wells-fargo-saying-doj-issue-isnt-new?source=tweet\" data-url=\"https://seekingalpha.com/news/3388477-evercore-isi-defends-wells-fargo-saying-doj-issue-isnt-new\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388476\" data-ts=\"1536259156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388476-kla-tencor-lowers-2h18-shipment-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KLA-Tencor lowers 2H18 shipment expectations</a></h4><ul><li>        KLA-Tencor (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='red'>-10%</font>) helped pull chip stocks down today after this morning&rsquo;s <a href=\"https://www.reuters.com/article/us-kla-kla-tencor-stocks/chip-gear-makers-slide-as-kla-tencor-cfo-warns-of-slowing-memory-chip-growth-idUSKCN1LM2OQ?feedType=RSS&amp;feedName=technologyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FtechnologyNews+%28Reuters+Technology+News%29\" target=\"_blank\">presentation at the Citi 2018 Global Technology Conference.</a> </li><li>        Key quote from CFO Bren Higgens: &ldquo;We thought that December quarter would snap back pretty strongly, when we look at it today &hellip; feels like it will be up a little less than what we thought. We see September is still in a drought.&rdquo;</li><li>               KLA-Tencor now expects 2H18 shipments to be flat to down a few single digits. Prior guidance put shipments at the mid-single digits growth.&nbsp;</li><li>               Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='red'>-8.7%</font>) CFO David Zinsner, presenting at the same conference: NAND pricing did decline in the third quarter.&rdquo; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388402-semi-stocks-slip-analysts-question-micron\" target=\"_blank\">Semi stocks slip after analysts question Micron</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388476\" data-linked=\"KLA-Tencor lowers 2H18 shipment expectations\" data-tweet=\"$KLAC $KLAC $MU - KLA-Tencor lowers 2H18 shipment expectations https://seekingalpha.com/news/3388476-kla-tencor-lowers-2h18-shipment-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3388476-kla-tencor-lowers-2h18-shipment-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388475\" data-ts=\"1536259108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388475-chevron-conocophillipsminus-3-after-baml-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron, ConocoPhillips each -3% after BAML downgrades</a></h4><ul>     <li>Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-3%</font>) and ConocoPhillips (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-3%</font>) are sharply lower after BofA&nbsp;Merrill Lynch <a href=\"https://www.cnbc.com/2018/09/06/bank-of-america-downgrades-chevron-on-energy-project-renewal-risk.html\" target=\"_blank\">downgraded</a> shares to Neutral from Buy.</li>     <li>CVX \"will continue to benefit from any continued strength in oil prices, but given emerging uncertainties around spending and PSC [production sharing contract] renewals... a more selective sector view that acknowledges the tailwind from the commodity as largely played out,\" writes BAML analyst Doug Leggate.</li>     <li>Multiple \"key production sharing contracts\" for CVX expire during 2021-23 and are up for renewal, and Leggate notes bidding for CVX's natural gas contracts in Thailand are especially competitive and represent 8% of the company's production.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388475\" data-linked=\"Chevron, ConocoPhillips each -3% after BAML downgrades\" data-tweet=\"$CVX $CVX $COP - Chevron, ConocoPhillips each -3% after BAML downgrades https://seekingalpha.com/news/3388475-chevron-conocophillipsminus-3-after-baml-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3388475-chevron-conocophillipsminus-3-after-baml-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388468\" data-ts=\"1536257532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/Z\" target=\"_blank\">Z</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388468-zillow-slips-7-keller-williams-crashes-mobile-space\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow slips more than 7% as Keller Williams crashes mobile space</a></h4><ul>   <li>A steady decline today has brought Zillow shares to seven-month lows (<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a> <font color='red'>-7.4%</font>, <a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a> <font color='red'>-7.8%</font>) today after real-estate firm Keller Williams made its mobile move with an <a href=\"https://therealdeal.com/2018/09/06/heres-how-keller-williams-plans-to-take-on-zillow-and-redfin/\" target=\"_blank\">acquisition of the SmarterAgent platform</a>.</li>    <li>Tech-focused real estate brokerage Redfin (NASDAQ:<a href='https://seekingalpha.com/symbol/RDFN' title='Redfin'>RDFN</a>) is <font color='red'>1.2% lower</font> today as well.</li>    <li>Keller Williams' deal is one of a string in recent months, and it points to a new approach ahead. &ldquo;We&rsquo;re going to be launching our new consumer strategy in the first quarter of next year and mobile will obviously be a big piece of that,&rdquo; says KW Chief Innovation Officer Josh Team.</li>    <li>Keller Williams is now the biggest client of SmarterAgent, which serves more than 300 other brokerages.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388468\" data-linked=\"Zillow slips more than 7% as Keller Williams crashes mobile space\" data-tweet=\"$Z $Z $ZG - Zillow slips more than 7% as Keller Williams crashes mobile space https://seekingalpha.com/news/3388468-zillow-slips-7-keller-williams-crashes-mobile-space?source=tweet\" data-url=\"https://seekingalpha.com/news/3388468-zillow-slips-7-keller-williams-crashes-mobile-space\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388467\" data-ts=\"1536257063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COL\" target=\"_blank\">COL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388467-rockwell-collins-said-near-clearance-from-china-on-united-tech-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rockwell Collins said near clearance from China on United Tech merger</a></h4><ul><li>Rockwell Collins (<a href='https://seekingalpha.com/symbol/COL' title='Rockwell Collins, Inc.'>COL</a> <font color='green'>+1.6%</font>) rockets higher after DealReporter says United Technologies' (<a href='https://seekingalpha.com/symbol/UTX' title='United Technologies Corporation'>UTX</a> <font color='green'>+0.6%</font>) takeover is expected to be approved by  China&rsquo;s State Administration for Market Regulation in the near  term.</li><li>Companies have offered additional behavioral remedies in the Chinese  market to gain acceptance for deal, and are now finalizing conditions, according to the report.</li><li>DealReporter says behavioral commitments are mainly addressing local customers&rsquo; concerns  on the deal and post-deal supply &ldquo;instability.&rdquo;</li><li>Source:&nbsp;Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3388467\" data-linked=\"Rockwell Collins said near clearance from China on United Tech merger\" data-tweet=\"$COL $COL $UTX - Rockwell Collins said near clearance from China on United Tech merger https://seekingalpha.com/news/3388467-rockwell-collins-said-near-clearance-from-china-on-united-tech-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3388467-rockwell-collins-said-near-clearance-from-china-on-united-tech-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388466\" data-ts=\"1536256855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDPI\" target=\"_blank\">SDPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388466-energy-materials-top-gainers-losers-of-2-00-pm-09-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (09/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a> <font color='green'>+19%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388466\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (09/06/2018)\" data-tweet=\"$SDPI $SDPI $NEXT - Energy/Materials - Top Gainers / Losers as of 2:00 PM (09/06/2018) https://seekingalpha.com/news/3388466-energy-materials-top-gainers-losers-of-2-00-pm-09-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3388466-energy-materials-top-gainers-losers-of-2-00-pm-09-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388454\" data-ts=\"1536255628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388454-barnes-noble-to-start-ceo-search-in-october\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble to start CEO search in October</a></h4><ul><li>Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='red'>-7.6%</font>) says it will begin looking for a new CEO following the retailer's annual shareholder meeting in October.</li><li>Shares of B&amp;N are having a rough session after earnings disappointed investors. BKS traded as low as $4.55 earlier in the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388454\" data-linked=\"Barnes &amp; Noble to start CEO search in October\" data-tweet=\"$BKS - Barnes &amp; Noble to start CEO search in October https://seekingalpha.com/news/3388454-barnes-noble-to-start-ceo-search-in-october?source=tweet\" data-url=\"https://seekingalpha.com/news/3388454-barnes-noble-to-start-ceo-search-in-october\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388449\" data-ts=\"1536254066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388449-tesla-and-musk-sued-citrons-left-for-securities-fraud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla and Musk sued by Citron&#39;s Left for securities fraud</a></h4><ul><li>Citron's Andrew Left has filed a lawsuit against Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) and Elon Musk for securities fraud, according to a court filing first <a href=\"https://twitter.com/Paul_M_Huettner/status/1037742602471333889\" target=\"_blank\">reported</a> by Paul Huettner.</li><li>The lawsuit covers a range of action by Tesla and Musk, although the two words \"funding secured\" from the infamous Musk tweet seem to be the lynchpin of the legal argument.</li><li><a href=\"https://www.dropbox.com/s/dml9bxz4rohzzbo/Left%20v.%20Tesla%2018-05463.pdf?dl=0\" target=\"_blank\">Full lawsuit filing</a> (.pdf)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388449\" data-linked=\"Tesla and Musk sued by Citron&#39;s Left for securities fraud\" data-tweet=\"$TSLA - Tesla and Musk sued by Citron&#39;s Left for securities fraud https://seekingalpha.com/news/3388449-tesla-and-musk-sued-citrons-left-for-securities-fraud?source=tweet\" data-url=\"https://seekingalpha.com/news/3388449-tesla-and-musk-sued-citrons-left-for-securities-fraud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>201&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388448\" data-ts=\"1536253959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388448-cel-sci-up-26-on-nih-selection-of-arthritis-vaccine-for-commercialization-accelerator-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CEL-SCI up 26% on NIH selection of arthritis vaccine for commercialization accelerator program</a></h4><ul><li>Nano cap CEL-SCI (<a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='green'>+26.3%</font>) is up on more than a 5x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17261363-nih-selects-cel-sci-s-leaps-rheumatoid-arthritis-vaccine-commercialization-accelerator\" target=\"_blank\">announcement </a>that NIH has selected its LEAPS rheumatoid vaccine candidate for inclusion in its Small Business Innovation Research/Small Business Technology Transfer Commercialization Accelerator Program.</li><li>As a Phase II awardee, NIH has selected LEAPS for its Commercialization Transition Track which provides for technical assistance to selected companies to move NIH-funded technologies towards the marketplace.</li><li>CEL-SCI applied for the program as part of its $1.5M Phase II SBIR/STTR NIH grant to develop the vaccine.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388448\" data-linked=\"CEL-SCI up 26% on NIH selection of arthritis vaccine for commercialization accelerator program\" data-tweet=\"$CVM - CEL-SCI up 26% on NIH selection of arthritis vaccine for commercialization accelerator program https://seekingalpha.com/news/3388448-cel-sci-up-26-on-nih-selection-of-arthritis-vaccine-for-commercialization-accelerator-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3388448-cel-sci-up-26-on-nih-selection-of-arthritis-vaccine-for-commercialization-accelerator-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388447\" data-ts=\"1536253431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388447-midday-gainers-losers-09-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (09/06/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/WSCI' title='WSI Industries Inc.'>WSCI</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/ABAC-OLD' title='Renmin Tianli Group'>ABAC-OLD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited ADR'>IMMP</a> <font color='green'>+15%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CKPT' title='CHECKPOINT THERAPEUTICS'>CKPT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MSON' title='MISONIX, Inc.'>MSON</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals'>RTTR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-11%</font>.</li>      &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3388447\" data-linked=\"Midday Gainers / Losers (09/06/2018)\" data-tweet=\"$ARWR $ARWR $WSCI - Midday Gainers / Losers (09/06/2018) https://seekingalpha.com/news/3388447-midday-gainers-losers-09-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3388447-midday-gainers-losers-09-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388444\" data-ts=\"1536253308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUPV\" target=\"_blank\">SUPV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388444-financials-top-5-gainers-losers-of-1-00-pm-09-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (09/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francs S.A.  ADR'>BFR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/EVER' title='EverQuote'>EVER</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388444\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (09/06/2018)\" data-tweet=\"$SUPV $SUPV $GGAL - Financials - Top 5 Gainers / Losers as of 1:00 PM (09/06/2018) https://seekingalpha.com/news/3388444-financials-top-5-gainers-losers-of-1-00-pm-09-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3388444-financials-top-5-gainers-losers-of-1-00-pm-09-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388435\" data-ts=\"1536252190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388435-biotechs-and-biopharmas-in-red\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechs and biopharmas in the red</a></h4><ul><li>Biotechs and Big Pharma players are getting roughed up as the session heads into the lunch hour. The SPDR S&amp;P Biotech ETF (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color='red'>-2.5%</font>) has lost over&nbsp;<font color='red'>3.5%&nbsp;</font>this week.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-2.6%</font>)(<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='red'>-15.8%</font>)(<a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a> <font color='red'>-2.8%</font>)(<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='red'>-7.3%</font>)(<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-3.5%</font>)(<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='red'>-4.3%</font>)(<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='red'>-5.7%</font>)(<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='red'>-3.2%</font>)(<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='red'>-4.9%</font>)(<a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color='red'>-1.3%</font>)(<a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-3.2%</font>)(<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-2.2%</font>)(<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color='red'>-2.3%</font>)(<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color='red'>-1.8%</font>)(<a href='https://seekingalpha.com/symbol/BPMC' title='Blueprint Medicines'>BPMC</a> <font color='red'>-3.3%</font>)(<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-1.4%</font>)(<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='red'>-2.8%</font>)(<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-2.8%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='red'>-4.3%</font>)(<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='red'>-4.5%</font>)(<a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a> <font color='red'>-3.3%</font>)(<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a> <font color='red'>-2.5%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='red'>-4%</font>)(<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='red'>-2.3%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='red'>-2.2%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-1.7%</font>)(<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='red'>-1.4%</font>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-1.7%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-4.2%</font>)(<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color='red'>-3.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388435\" data-linked=\"Biotechs and biopharmas in the red\" data-tweet=\"$IONS $XBI $IONS - Biotechs and biopharmas in the red https://seekingalpha.com/news/3388435-biotechs-and-biopharmas-in-red?source=tweet\" data-url=\"https://seekingalpha.com/news/3388435-biotechs-and-biopharmas-in-red\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388434\" data-ts=\"1536252165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388434-pg-and-e-upgraded-to-buy-argus-after-california-legislative-win\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E upgraded to Buy at Argus after California legislative win</a></h4><ul>     <li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-3.6%</font>) is lower despite receiving an <a href=\"https://thefly.com/thestreet/realmoney/index.php/PCGid2786688/PCG-PGE-upgraded-to-Buy-at-Argus-after-its-California-legislative-win\" target=\"_blank\">upgrade to Buy</a> from Hold with a $54 price target at Argus, where analyst Jacob Kilstein says the company's <a href=\"https://seekingalpha.com/news/3387467-pg-and-e-plus-4-percent-baml-evercore-isi-upgrade-california-fire-legislation\" target=\"_blank\">recent California legislative victory</a> will reduce its liability for last year's wildfire as its earnings outlook improves.</li><li>Kilstein expects PG&amp;E will announce a timeline regarding its dividend reinstatement after being forced to suspend its quarterly payout on concerns about its potential wildfire damage responsibility estimated as high as $12B.</li>     <li>The analyst also raised his FY 2018 EPS outlook to $3.82 from $3.72 while noting that PG&amp;E's valuation of 12.3x his expected 2018 earnings is well below the industry average of 18.1x.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388434\" data-linked=\"PG&amp;E upgraded to Buy at Argus after California legislative win\" data-tweet=\"$PCG - PG&amp;E upgraded to Buy at Argus after California legislative win https://seekingalpha.com/news/3388434-pg-and-e-upgraded-to-buy-argus-after-california-legislative-win?source=tweet\" data-url=\"https://seekingalpha.com/news/3388434-pg-and-e-upgraded-to-buy-argus-after-california-legislative-win\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388433\" data-ts=\"1536251496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388433-maryland-ag-charges-insys-therapeutics-violating-consumer-protection-act-shares-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maryland AG charges Insys Therapeutics with violating Consumer Protection Act; shares down 7%</a></h4><ul><li>The Consumer Protection Division of the Office of the Attorney General for the state of Maryland has <a href=\"http://www.marylandattorneygeneral.gov/press/2018/090618.pdf\" target=\"_blank\">charged </a>INSYS Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-6.8%</font>) with multiple violations of the Consumer Protection Act related to its marketing practices for opioid pain med Subsys (fentanyl).</li><li>Specifically, the CPD accuses the company, and certain local healthcare providers, of targeting off-label non-cancer uses, including chronic pain syndrome, knee pain, back pain and migraines. It also accuses it of masking large prescription-stoking kickbacks to certain doctors via its Speaker Program.</li><li>This is yet another lawsuit dogging the company amidst the U.S. opioid crisis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3379994-insys-settle-doj-investigation-150m\" target=\"_blank\">INSYS to settle DOJ investigation for $150M</a> (Aug. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360559-minnesota-sues-insys-drug-marketing\" target=\"_blank\">Minnesota sues Insys over drug marketing</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388433\" data-linked=\"Maryland AG charges Insys Therapeutics with violating Consumer Protection Act; shares down 7%\" data-tweet=\"$INSY $INSYQ - Maryland AG charges Insys Therapeutics with violating Consumer Protection Act; shares down 7% https://seekingalpha.com/news/3388433-maryland-ag-charges-insys-therapeutics-violating-consumer-protection-act-shares-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3388433-maryland-ag-charges-insys-therapeutics-violating-consumer-protection-act-shares-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388428\" data-ts=\"1536250638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTTR\" target=\"_blank\">RTTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388428-ritter-pharma-down-12-after-corporate-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ritter Pharma down 12% after corporate presentation</a></h4><ul><li>Thinly traded nano cap Ritter Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals'>RTTR</a> <font color='red'>-12.4%</font>) slips on modestly higher volume. Yesterday after the close, CEO Andrew Ritter delivered a <a href=\"http://www.ritterpharmaceuticals.com/ritter-pharmaceuticals-to-present-at-20th-annual-hc-wainwright-global-investment-conference-on-september-5-2018\" target=\"_blank\">presentation </a>at the H.C. Wainwright Global Investment Conference in New York City during which he addressed the clinical program for lactose intolerance candidate RP-G28, the company's business model and growth strategy.</li><li>It has yet to post the slides on its website.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388428\" data-linked=\"Ritter Pharma down 12% after corporate presentation\" data-tweet=\"$RTTR - Ritter Pharma down 12% after corporate presentation https://seekingalpha.com/news/3388428-ritter-pharma-down-12-after-corporate-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3388428-ritter-pharma-down-12-after-corporate-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388422\" data-ts=\"1536249629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABAC-OLD\" target=\"_blank\">ABAC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388422-consumer-top-5-gainers-losers-of-12-00-pm-09-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ABAC-OLD' title='Renmin Tianli Group'>ABAC-OLD</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/REVG' title='REV Group'>REVG</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388422\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/06/2018)\" data-tweet=\"$ABAC-OLD $ABAC-OLD $NBEV - Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/06/2018) https://seekingalpha.com/news/3388422-consumer-top-5-gainers-losers-of-12-00-pm-09-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3388422-consumer-top-5-gainers-losers-of-12-00-pm-09-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388421\" data-ts=\"1536249499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388421-report-cbs-directors-seek-autonomy-amid-moonves-exit-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: CBS directors seek autonomy amid Moonves exit talks</a></h4><ul>   <li>As part of reported <a href=\"https://seekingalpha.com/news/3388320-cbs-minus-2-percent-report-board-negotiating-moonves-exit\" target=\"_blank\">negotiations for the exit</a> of <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> CEO Les Moonves, company directors are asking for <a href=\"https://www.wsj.com/articles/cbs-directors-les-moonves-negotiating-his-exit-as-ceo-1536248559?mod=searchresults&amp;page=1&amp;pos=1\" target=\"_blank\">assurances of autonomy</a> from controlling shareholder National Amusements, the <em>WSJ</em> reports.</li>    <li>The boardmembers want the Redstone family to amend its trust to give CBS assurances that it could pursue deals without Shari Redstone standing in the way, according to the report. (The trust <a href=\"https://seekingalpha.com/news/3381129-wsj-redstone-trust-restricts-cbs-viacom-sale-prospects\" target=\"_blank\">limits the ability of CBS and Viacom</a> (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+0.5%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+0.1%</font>) to be sold to a large buyer after the death of 95-year-old Sumner Redstone.)</li>    <li>CBS shares that were lower earlier have turned significantly higher in the late morning, now <font color='green'>up 3.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388421\" data-linked=\"Report: CBS directors seek autonomy amid Moonves exit talks\" data-tweet=\"$CBS $VIAC $VIA - Report: CBS directors seek autonomy amid Moonves exit talks https://seekingalpha.com/news/3388421-report-cbs-directors-seek-autonomy-amid-moonves-exit-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3388421-report-cbs-directors-seek-autonomy-amid-moonves-exit-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388420\" data-ts=\"1536249428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNT\" target=\"_blank\">VRNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388420-guidewire-verint-and-ss-and-c-pull-up-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidewire, Verint, and SS&amp;C pull up peers</a></h4><ul><li>        The earnings reports of Verint Systems (<a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='green'>+7.7%</font>) and Guidewire Software (<a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a> <font color='green'>+3.2%</font>) join SS&amp;C&rsquo;s (<a href='https://seekingalpha.com/symbol/SSNC' title='SS&C Technologies Holdings, Inc.'>SSNC</a> <font color='green'>+0.5%</font>) confirmed acquisition of Intralinks in pulling up some of their business software peers.</li><li>               On the move up: Q2 Holdings (<a href='https://seekingalpha.com/symbol/QTWO' title='Q2 Holdings, Inc.'>QTWO</a> <font color='green'>+2.3%</font>), EVO Payments (<a href='https://seekingalpha.com/symbol/EVOP' title='Evo Payments'>EVOP</a> <font color='green'>+1.6%</font>), NetScout (<a href='https://seekingalpha.com/symbol/NTCT' title='NetScout Systems, Inc.'>NTCT</a> <font color='green'>+1.6%</font>), Fair Isaac (<a href='https://seekingalpha.com/symbol/FICO' title='Fair Isaac Corporation'>FICO</a> <font color='green'>+1.4%</font>), CyberArk (<a href='https://seekingalpha.com/symbol/CYBR' title='CyberArk Software Ltd.'>CYBR</a> <font color='green'>+1.4%</font>), Pegasystems (<a href='https://seekingalpha.com/symbol/PEGA' title='Pegasystems Inc.'>PEGA</a> <font color='green'>+0.4%</font>).&nbsp;&nbsp;</li><li>Software ETFs: <a href='https://seekingalpha.com/symbol/IGV' title='iShares Expanded Tech-Software Sector ETF'>IGV</a>, <a href='https://seekingalpha.com/symbol/PSJ' title='Invesco Dynamic Software Portfolio ETF'>PSJ</a>, <a href='https://seekingalpha.com/symbol/XSW' title='SPDR Software & Services ETF'>XSW</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3388327-ss-and-c-acquire-intralinks\" target=\"_blank\">SS&amp;C to acquire Intralinks</a> (Sept. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388162-verint-systems-plus-11-percent-q2-beats-raised-fy-guidance\" target=\"_blank\">Verint Systems +11% on Q2 beats, raised FY guidance</a> (Sept. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388148-guidewire-software-minus-7-percent-downside-fy-guidance\" target=\"_blank\">Guidewire Software -7% on downside FY guidance</a> (Sept. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388414-docusign-earnings-puts-pressure-business-software-peers\" target=\"_blank\">DocuSign earnings puts pressure on business software peers</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388420\" data-linked=\"Guidewire, Verint, and SS&amp;C pull up peers\" data-tweet=\"$VRNT $VRNT $GWRE - Guidewire, Verint, and SS&amp;C pull up peers https://seekingalpha.com/news/3388420-guidewire-verint-and-ss-and-c-pull-up-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3388420-guidewire-verint-and-ss-and-c-pull-up-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388417\" data-ts=\"1536249140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASFI\" target=\"_blank\">ASFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388417-asta-funding-surges-after-continued-listing-plan-accepted-nasdaq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asta Funding surges after continued listing plan accepted by Nasdaq</a></h4><ul><li>Thinly traded Asta Funding (NASDAQ:<a href='https://seekingalpha.com/symbol/ASFI' title='Asta Funding, Inc.'>ASFI</a>)&nbsp;<font color='green'>jumps 11%</font>&nbsp;after Nasdaq accepts the <a href=\"https://seekingalpha.com/pr/17263151-asta-funding-inc-continued-listing-plan-accepted-nasdaq\" target=\"_blank\">company's&nbsp;plan</a> for continued listing on the Nasdaq Global Select Market.</li><li>Nasdaq's hearing panel allowed to continue the listing of Asta's common stock while the company works to file all restated and delayed periodic reports due to be filed with the SEC.</li><li>On or before Nov. 30, 2018, Asta must be current with all SEC periodic public filings, which include each Form 10-Q for periods ending Dec. 31, 2017, March 31, 2018 and June 30, 2018.</li><li>Asta Funding says it's doing everything within its control to file the required SEC reports as soon as practicable, but there's no assurance that it will be able to meet the panel's deadline.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287514-asta-funding-reports-q3-results\" target=\"_blank\">Asta Funding reports Q3 results</a> (Aug. 9, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388417\" data-linked=\"Asta Funding surges after continued listing plan accepted by Nasdaq\" data-tweet=\"$ASFI - Asta Funding surges after continued listing plan accepted by Nasdaq https://seekingalpha.com/news/3388417-asta-funding-surges-after-continued-listing-plan-accepted-nasdaq?source=tweet\" data-url=\"https://seekingalpha.com/news/3388417-asta-funding-surges-after-continued-listing-plan-accepted-nasdaq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388414\" data-ts=\"1536248799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388414-docusign-earnings-puts-pressure-on-business-software-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DocuSign earnings puts pressure on business software peers</a></h4><ul><li>DocuSign&rsquo;s (<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a> <font color='red'>-7%</font>) earnings report yesterday is pulling down business software peers including other recent IPOs.</li><li>Peers feeling pressure: Tenable (<a href='https://seekingalpha.com/symbol/TENB' title='Tenable Holdings'>TENB</a> <font color='red'>-6.3%</font>), Smartsheet (<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a> <font color='red'>-4.7%</font>), Descarte Systems (<a href='https://seekingalpha.com/symbol/DSGX' title='Descartes Systems Group Inc. &#40;The&#41;'>DSGX</a> <font color='red'>-2.9%</font>), Asure Software (<a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a> <font color='red'>-2.5%</font>), Zuora (<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='red'>-1.3%</font>), Dropbox (<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox'>DBX</a> <font color='red'>-3.3%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388134-docusign-minus-2_6-percent-despite-q2-beats-upside-guides\" target=\"_blank\">DocuSign -2.6% despite Q2 beats, upside guides</a> (Sept. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388383-tenable-slides-6-percent-despite-earnings-beat-upside-guidance\" target=\"_blank\">Tenable slides ~6% despite earnings beat and upside guidance</a> (Sept. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388381-descartes-systems-2_5-percent-post-q2-results\" target=\"_blank\">Descartes Systems down 2.5% post Q2 results</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388414\" data-linked=\"DocuSign earnings puts pressure on business software peers\" data-tweet=\"$DOCU $DOCU $TENB - DocuSign earnings puts pressure on business software peers https://seekingalpha.com/news/3388414-docusign-earnings-puts-pressure-on-business-software-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3388414-docusign-earnings-puts-pressure-on-business-software-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388410\" data-ts=\"1536248157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388410-cloudera-mongodb-earnings-pull-up-application-software-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudera, MongoDB earnings pull up application software peers</a></h4><ul><li>        Application software stocks get a boost from yesterday&rsquo;s earnings reports from Cloudera (<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a> <font color='green'>+21.4%</font>) and MongoDB (<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='green'>+6%</font>). Dell (DVMT) reported this morning and gave a lift to SecureWorks (<a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a> <font color='green'>+1.4%</font>), which has Dell as its majority owner.&nbsp;</li><li>                  Other industry gainers: Avalara (<a href='https://seekingalpha.com/symbol/AVLR' title='Avalara'>AVLR</a> <font color='green'>+2%</font>), Mitek Systems (<a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems Inc.'>MITK</a> <font color='green'>+2.8%</font>), Box (<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a> <font color='green'>+2.7%</font>), HubSpot (<a href='https://seekingalpha.com/symbol/HUBS' title='HubSpot, Inc.'>HUBS</a> <font color='green'>+3%</font>), ForeScout (<a href='https://seekingalpha.com/symbol/FSCT' title='ForeScout Technologies, Inc.'>FSCT</a> <font color='green'>+2.8%</font>), Domo (<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a> <font color='green'>+2.2%</font>), Progress Software (<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a> <font color='green'>+1.2%</font>), Workday (<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a> <font color='green'>+1.2%</font>).&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3388157-mongodb-minus-5_7-percent-q2-beats-mixed-fy-guidance\" target=\"_blank\">MongoDB -5.7% after Q2 beats with mixed FY guidance</a> (Sept. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388145-cloudera-plus-10-percent-q2-subscription-strength-upside-guidance\" target=\"_blank\">Cloudera +10% on Q2 subscription strength, upside guidance</a> (Sept. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388267-dell-reports-q2-segment-growths-raises-fy-guidance\" target=\"_blank\">Dell reports Q2 segment growths, raises FY guidance</a> (Sept. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388289-canaccord-genuity-raises-hubspot-15-percent-upside\" target=\"_blank\">Canaccord Genuity raises Hubspot to 15% upside</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388410\" data-linked=\"Cloudera, MongoDB earnings pull up application software peers\" data-tweet=\"$CLDR $CLDR $MDB - Cloudera, MongoDB earnings pull up application software peers https://seekingalpha.com/news/3388410-cloudera-mongodb-earnings-pull-up-application-software-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3388410-cloudera-mongodb-earnings-pull-up-application-software-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388406\" data-ts=\"1536247704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANCUF\" target=\"_blank\">ANCUF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388406-alimentation-couche-tard-up-3_9-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alimentation Couche-Tard up 3.9% post Q1 results</a></h4><ul><li>Alimentation Couche-Tard (<a href='https://seekingalpha.com/symbol/ANCUF' title='Alimentation Couche-Tard Inc.'>OTCPK:ANCUF</a> <font color='green'>+3.9%</font>) <u><a href=\"https://seekingalpha.com/pr/17262143-alimentation-couche-tard-announces-results-first-quarter-fiscal-year-2019\" target=\"_blank\">reports Q1</a></u>&nbsp;revenue growth of 27.7% Y/Y to $3.6B.</li><li>Total merchandise and service revenues of $3.5B (+27.6% Y/Y), Same-store merchandise revenues increased by&nbsp;<font color='green'>4.2%</font>&nbsp;in the&nbsp;U.S.,&nbsp;<font color='green'>7.3%</font>&nbsp;in&nbsp;Europe&nbsp;and by&nbsp;<font color='green'>6.6%</font>&nbsp;in&nbsp;Canada.</li><li>Merchandise and service gross margin&nbsp;<font color='green'>increased 20 bps</font>&nbsp;in the&nbsp;U.S. to 33.5%,&nbsp;<font color='green'>increased 30 bps</font>&nbsp;in&nbsp;Europe&nbsp;at 42.4% and, in&nbsp;Canada, it&nbsp;<font color='red'>declined 50 bps</font>&nbsp;to 34.5%.</li><li>Total road transportation fuel volumes grew by&nbsp;31.9%; Same-store road transportation fuel volumes increased by&nbsp;<font color='green'>0.6%</font>&nbsp;in the&nbsp;U.S.&nbsp;while declined by&nbsp;<font color='red'>0.1%&nbsp;</font>in&nbsp;Europe &amp;&nbsp;<font color='red'>3.3%</font>&nbsp;in Canada.</li><li>Current annual synergies run rate related to the CST integration reached ~$189M.</li><li>Adjusted leverage ratio improved to 2.86:1.</li><li>Road transportation fuel gross margin increased by US 1.95&cent; per gallon in the&nbsp;U.S.&nbsp;to US 22.70&cent; per gallon, by US 0.24&cent; per litre in&nbsp;Europe, to US 9.21&cent; per litre and by CA 0.69&cent; per litre in&nbsp;Canada, to CA 8.91&cent; per litre.</li><li>Return on equity and return on capital employed at 24.8% and 12.3%, respectively.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388175-alimentation-couche-tard-reports-q1-results\" target=\"_blank\">Alimentation Couche-Tard reports Q1 results</a> (Sept. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388406\" data-linked=\"Alimentation Couche-Tard up 3.9% post Q1 results\" data-tweet=\"$ANCUF - Alimentation Couche-Tard up 3.9% post Q1 results https://seekingalpha.com/news/3388406-alimentation-couche-tard-up-3_9-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3388406-alimentation-couche-tard-up-3_9-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388407\" data-ts=\"1536247497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MESA\" target=\"_blank\">MESA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388407-mesa-air-rally-loses-steam\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mesa Air rally loses steam</a></h4><ul><li>Mesa Air Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MESA' title='Mesa Air Group'>MESA</a>) <font color='red'>sheds 7.6%</font> to give back some of the gains accumulated this week after analyst coverage launched on the airline stock.</li><li>One of the stronger notes on Mesa was from Imperial Capital (Outperform, $18 price target). The firm <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/09/12306686/mesa-air-group-5-reasons-why-imperial-capital-is-bullis\" target=\"_blank\">pointed</a> to Mesa's long-term capacity agreements with American Airlines and United, as well as the carrier's focus on larger jets and the low-cost business model.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388407\" data-linked=\"Mesa Air rally loses steam\" data-tweet=\"$MESA - Mesa Air rally loses steam https://seekingalpha.com/news/3388407-mesa-air-rally-loses-steam?source=tweet\" data-url=\"https://seekingalpha.com/news/3388407-mesa-air-rally-loses-steam\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388405\" data-ts=\"1536247473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388405-fgl-holdingsplus-2_8-after-announcing-exchange-offer-for-warrants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FGL Holdings +2.8% after announcing exchange offer for warrants</a></h4><ul><li>FGL Holdings<font color='green'> gains 2.8% </font>after announcing<a href=\"https://seekingalpha.com/pr/17262356-fgl-holdings-announces-exchange-offer-warrants\" target=\"_blank\"> plans to offer to exchange</a>&nbsp;its outstanding warrants for a combination of stock and cash, in an effort to provide greater clarity on potential dilution of its shares.</li><li>If the offer is consummated, FGL Holdings' shareholders will be less likely to have their stakes' diluted as the result of warrants being exercised as warrants tendered in the exchange offer will be canceled.</li><li>The company offers to issue 0.11 of FGL Holdings' ordinary shares, par value $0.0001, and 98 cents in cash per warrant. As of Sept. 5, 2018, FGL had 70,883,334 outstanding warrants to purchase its ordinary shares.</li><li>Based on the Sept. 5 price of ordinary shares of $8.92, total value of the exchange consideration would have been $1.96 per warrant, representing about 35% premium over the Sept. 5 price of warrants at $1.45.</li><li>FGL directors and sponsor group Blackstone, who collectively hold about 36.5% of the outstanding warrants, have confirmed their intent to tender all of the warrants they hold.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3380457-fgl-holdings-beats-0_01-misses-revenue\" target=\"_blank\">FGL Holdings beats by $0.01, misses on revenue</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388405\" data-linked=\"FGL Holdings +2.8% after announcing exchange offer for warrants\" data-tweet=\"FGL Holdings +2.8% after announcing exchange offer for warrants https://seekingalpha.com/news/3388405-fgl-holdingsplus-2_8-after-announcing-exchange-offer-for-warrants?source=tweet\" data-url=\"https://seekingalpha.com/news/3388405-fgl-holdingsplus-2_8-after-announcing-exchange-offer-for-warrants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388402\" data-ts=\"1536247327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388402-semi-stocks-slip-after-analysts-question-micron\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semi stocks slip after analysts question Micron</a></h4><ul><li>        Semiconductor stocks are sliding after analyst doubts on Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='red'>-10.4%</font>) and KLA-Tencor (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='red'>-9.5%</font>) presented at the Citi Global Technology Conference.</li><li>               Baird removed Micron as a top idea and Morgan Stanley <a href=\"https://www.bloomberg.com/news/articles/2018-09-06/semiconductors-plunge-on-kla-tencor-comments-memory-demand-woes?srnd=markets-vp\" target=\"_blank\">wrote a note</a> saying memory markets are worsening into Q4 on inventory and pricing concerns. The firm says weaker DRAM demand is creating an inventory surplus and pressuring prices. &nbsp;&nbsp;</li><li>               Other semi stocks that can move on the news: Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='red'>-4.1%</font>), &nbsp;ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color='red'>-5.3%</font>), Ichor (<a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-9%</font>), Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='red'>-6%</font>), Ultra Clean Holdings (<a href='https://seekingalpha.com/symbol/UCTT' title='Ultra Clean Holdings, Inc.'>UCTT</a> <font color='red'>-6.9%</font>), Brooks Automation (<a href='https://seekingalpha.com/symbol/BRKS' title='Brooks Automation, Inc.'>BRKS</a> <font color='red'>-4.8%</font>), AXT (<a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a> <font color='red'>-2.6%</font>), Nanometrics (<a href='https://seekingalpha.com/symbol/NANO' title='Nanometrics Incorporated'>NANO</a> <font color='red'>-4.3%</font>), Nova Measuring Instruments (<a href='https://seekingalpha.com/symbol/NVMI' title='Nova Measuring Instruments Ltd.'>NVMI</a> <font color='red'>-3.8%</font>), Axcelis Technologies (<a href='https://seekingalpha.com/symbol/ACLS' title='Axcelis Technologies, Inc.'>ACLS</a> <font color='red'>-4.4%</font>), Ambarella (<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color='green'>+2%</font>), Universal Display (<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='red'>-3.1%</font>), Synopsys (<a href='https://seekingalpha.com/symbol/SNPS' title='Synopsys, Inc.'>SNPS</a> <font color='green'>+0.1%</font>), and Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a> <font color='red'>-3.4%</font>).&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Related ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3388319-baird-removes-micron-top-ideas-lowers-target-nand-dram-pricing\" target=\"_blank\">Baird removes Micron from top ideas, lowers target on NAND/DRAM pricing</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388402\" data-linked=\"Semi stocks slip after analysts question Micron\" data-tweet=\"$MU $MU $KLAC - Semi stocks slip after analysts question Micron https://seekingalpha.com/news/3388402-semi-stocks-slip-after-analysts-question-micron?source=tweet\" data-url=\"https://seekingalpha.com/news/3388402-semi-stocks-slip-after-analysts-question-micron\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>143&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388401\" data-ts=\"1536247145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/III\" target=\"_blank\">III</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388401-isg-makes-7m-payment-to-reduce-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ISG makes $7M payment to further reduce debt</a></h4><ul>     <li>Information Services Group (<a href='https://seekingalpha.com/symbol/III' title='Information Services Group, Inc.'>III</a> <font color='red'>-2.1%</font>) has further reduced its debt through the repayment in full upon maturity of the unsecured subordinated promissory notes issued in connection with its Dec. 1, 2016 acquisition of Alsbridge Holdings, Inc.</li>     <li>ISG repaid the $7M of principal this week. The payment was made from cash on hand and is consistent with the firm's strategy of continuing to deleverage its balance sheet.</li><li><a href=\"https://seekingalpha.com/pr/17262858-isg-makes-7-million-payment-reduce-debt\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3388401\" data-linked=\"ISG makes $7M payment to further reduce debt\" data-tweet=\"$III - ISG makes $7M payment to further reduce debt https://seekingalpha.com/news/3388401-isg-makes-7m-payment-to-reduce-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3388401-isg-makes-7m-payment-to-reduce-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388395\" data-ts=\"1536246862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCI\" target=\"_blank\">DCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388395-donaldsonplus-5-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Donaldson +5% post Q4 results</a></h4><ul><li>Donaldson (<a href='https://seekingalpha.com/symbol/DCI' title='Donaldson Co Inc.'>DCI</a> <font color='green'>+5%</font>) reported Q4 net sale growth of 9.8% Y/Y to $724.7M. Sales by segments: Engine products $492.2M (+14% Y/Y) and Industrial products $232.5M (+1.9% Y/Y).</li><li>Sales increase Y/Y by Geography: US/CA +8.4%, EMEA +9.9%, APAC+13.1% and LATAM +7.6%.</li><li>Q4 Gross margin&nbsp;<font color='green'>improved by 10 bps</font>&nbsp;to 34.9%; operating margin<font color='green'> improved by 45 bps</font>&nbsp;to 14.7% and EBITDA margin<font color='green'> improved by 10 bps</font>&nbsp;to 17.7%.</li><li>Q4 Free cash flow of $81.4M, compare to $64.7 a year ago.</li><li>Company had Cash and cash equivalents of $204.7M as of July 31, 2018.</li><li>Donaldson repurchased 0.3M shares during the quarter for $14.3M.</li><li><strong>FY19 Guidance:</strong> Sales growth between 6-10%; GAAP EPS of $2.29-2.43; Adj. EPS $1.36-2; Operating margin 14.1-14.5%; Interest expense ~$22M; Other income $12-16M; Tax rate 24.7-26.7% and Capex $130-150M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388245-donaldson-eps-line-misses-revenue\" target=\"_blank\">Donaldson EPS in-line, misses on revenue</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388395\" data-linked=\"Donaldson +5% post Q4 results\" data-tweet=\"$DCI - Donaldson +5% post Q4 results https://seekingalpha.com/news/3388395-donaldsonplus-5-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3388395-donaldsonplus-5-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388394\" data-ts=\"1536246394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JW.A\" target=\"_blank\">JW.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388394-wileyminus-8_2-profits-miss-amid-declines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wiley -8.2% as profits miss amid declines</a></h4><ul>   <li>John Wiley &amp; Sons (NYSE:<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a>) is <font color='red'>off 7.1%</font> and at a nine-month low after profits fell short in <a href=\"https://seekingalpha.com/news/3388282-john-wiley-and-sons-misses-0_07-misses-revenue\" target=\"_blank\">fiscal Q1 earnings</a> amid overall declines in metrics.</li>    <li>On a non-GAAP basis, revenues, operating income and EPS all fell in constant currency terms as the company continued to make investments in growth initiatives and technology.</li>    <li>Performance was \"consistent with our expectations,\" says CEO Brian Napack.</li>    <li>Revenues were near flat but fell 0.7% in constant currency; operating income rose on a GAAP basis to $36.1M</li>    <li>Revenue breakout: Journal Subscriptions, $166M (down 1%); Open Access, $10.9M (up 24%); Licensing, Reprints, Backfiles, and Other, $39.5M (up 3%); Total Journal Revenue, $216.4M (flat); Publishing Technology Services (Atypon), $8.6M (up 4%).</li>    <li>For the full year, it's guiding to revenues that will be flat in constant currency and EPS to decline in the mid-single digits from fiscal 2018's $3.43. Cash from operations is expected to decline in the high single digits.</li>    <li>It's forecasting low-single digit revenue growth in Research and Solutions, offset by a low-single digit decline in Publishing revenues.</li>    <li><a href=\"https://seekingalpha.com/pr/17262622-wiley-reports-first-quarter-fiscal-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3388394\" data-linked=\"Wiley -8.2% as profits miss amid declines\" data-tweet=\"$JW.A $JW.B - Wiley -8.2% as profits miss amid declines https://seekingalpha.com/news/3388394-wileyminus-8_2-profits-miss-amid-declines?source=tweet\" data-url=\"https://seekingalpha.com/news/3388394-wileyminus-8_2-profits-miss-amid-declines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388393\" data-ts=\"1536246381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IFF\" target=\"_blank\">IFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388393-international-flavors-fragrances-provides-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Flavors &amp; Fragrances provides update</a></h4><ul> <li>International Flavors &amp; Fragrances (<a href='https://seekingalpha.com/symbol/IFF' title='International Flavors & Fragrances Inc.'>IFF</a> <font color='green'>+2.2%</font>) provides a business update ahead of its presentation at the Barclays Global Consumer Staples Conference.</li>          <li>The company says the combination of itself and Frutarom positions the combined entity as a global leader in taste, scent and nutrition.</li><li>\"We believe this       will translate into accelerated financial performance as a combined       company, with robust top and bottom-line growth,\" says CEO Andreas Fibig.</li><li>A sales target of 5% to 7% growth is unveiled and an EPS growth target of 10% (currency neutral) is established.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17262365-iff-share-strong-progress-frutarom-combination-barclays-global-consumer-staples-conference\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388393\" data-linked=\"International Flavors &amp; Fragrances provides update\" data-tweet=\"$IFF - International Flavors &amp; Fragrances provides update https://seekingalpha.com/news/3388393-international-flavors-fragrances-provides-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3388393-international-flavors-fragrances-provides-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388389\" data-ts=\"1536246100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CENX\" target=\"_blank\">CENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388389-century-aluminumplus-6-worlds-largest-alumina-refinery-boosts-output\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Century Aluminum +6% as world&#39;s largest alumina refinery boosts output</a></h4><ul>     <li>Century Aluminum (<a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+5.8%</font>) surges after Norsk Hydro (<a href='https://seekingalpha.com/symbol/NHYDY' title='Norsk Hydro ASA ADR'>OTCQX:NHYDY</a> <font color='green'>+2.4%</font>) signed deals with Brazilian authorities to <a href=\"https://www.reuters.com/article/norsk-hydro-brazil/update-2-norsk-hydro-signs-brazil-deals-aiming-to-resume-full-output-idUSL2N1VS05U\" target=\"_blank\">resume normal operations</a> at the world&rsquo;s largest alumina refinery, Alunorte, after operating at 50% capacity since March; CENX peer Alcoa (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-3.2%</font>) fell on news of the deal.</li><li>Bloomberg analyst Andrew Cosgrove had said that if Brazilian  courts ruled in Alunorte&rsquo;s favor and allowed the company to ramp up back  to full capacity, things could turn quickly in favor of not only Norsk  Hydro but also CENX and other aluminum makers that are net short the  commodity (source:&nbsp;Bloomberg First Word).</li><li>Cosgrove said higher alumina prices would have been beneficial for AA and South32 (<a href='https://seekingalpha.com/symbol/SOUHY' title='South32 Ltd. ADR'>OTCPK:SOUHY</a>), with Alcoa's EBITDA moving $80M and South32 shifting $67M for every $10 change in the alumina  price.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a>, <a href='https://seekingalpha.com/symbol/JJUB' title='iPath Series B Bloomberg Aluminum Subindex Total Return ETN'>JJUB</a></li>     </ul><div class=\"tiny-share-widget\" data-id=\"3388389\" data-linked=\"Century Aluminum +6% as world&#39;s largest alumina refinery boosts output\" data-tweet=\"$CENX $CENX $NHYDY - Century Aluminum +6% as world&#39;s largest alumina refinery boosts output https://seekingalpha.com/news/3388389-century-aluminumplus-6-worlds-largest-alumina-refinery-boosts-output?source=tweet\" data-url=\"https://seekingalpha.com/news/3388389-century-aluminumplus-6-worlds-largest-alumina-refinery-boosts-output\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388388\" data-ts=\"1536246044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388388-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>-4.3M</strong> barrels vs. -1.3M consensus, -2.6M last week.</li><li>Gasoline <strong>+1.8M</strong> barrels vs. -0.8M consensus, -1.6M last week.</li><li>Distillates<strong>&nbsp;+3.1M</strong> barrels vs. +0.7M consensus, -0.8M last week.</li><li>Futures<font color='red'>&nbsp;-0.32%</font>&nbsp;to $68.50.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3388388\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3388388-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3388388-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388387\" data-ts=\"1536246030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388387-healthcare-top-5-gainers-losers-of-11-00-09-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+57%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited ADR'>IMMP</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CKPT' title='CHECKPOINT THERAPEUTICS'>CKPT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ZLAB' title='Zai Lab Ltd.'>ZLAB</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MSON' title='MISONIX, Inc.'>MSON</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals'>RTTR</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388387\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/06/2018)\" data-tweet=\"$ARWR $ARWR $CVM - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/06/2018) https://seekingalpha.com/news/3388387-healthcare-top-5-gainers-losers-of-11-00-09-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3388387-healthcare-top-5-gainers-losers-of-11-00-09-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388384\" data-ts=\"1536245800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388384-wells-fargo-slips-after-report-of-wholesale-banking-unit-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo slips after report of wholesale banking unit probe</a></h4><ul><li>Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='red'>-1.5%</font>) dips after the<a href=\"https://www.wsj.com/articles/justice-department-probing-wells-fargos-wholesale-banking-unit-1536244490\" target=\"_blank\"> <em>Wall Street Journal </em>reports</a> that the U.S. Justice Department is investigating whether the bank's employees committed fraud in improperly changing customer information.</li><li>In recent weeks the Justice Department requested more information to examine if management pressure prompted employees to improperly change or add information, the<em> WSJ</em> reports, citing people familiar with the matter.</li><li>The newspaper had previously reported that employees in the wholesale banking unit, the part of the bank that deals with corporate customers, mishandled documents last year as they were working to get them ready to meet a regulatory deadline.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3375145-wells-fargo-wholesale-exec-making-exit\" target=\"_blank\">Wells Fargo wholesale exec making exit</a> (July 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3357639-wells-employees-altered-docs-wsj\" target=\"_blank\">Wells employees altered docs - WSJ</a> (May 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388384\" data-linked=\"Wells Fargo slips after report of wholesale banking unit probe\" data-tweet=\"$WFC - Wells Fargo slips after report of wholesale banking unit probe https://seekingalpha.com/news/3388384-wells-fargo-slips-after-report-of-wholesale-banking-unit-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3388384-wells-fargo-slips-after-report-of-wholesale-banking-unit-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388381\" data-ts=\"1536245362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSGX\" target=\"_blank\">DSGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388381-descartes-systems-down-2_5-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Descartes Systems down 2.5% post Q2 results</a></h4><ul><li>Descartes Systems (<a href='https://seekingalpha.com/symbol/DSGX' title='Descartes Systems Group Inc. &#40;The&#41;'>DSGX</a> <font color='red'>-2.6%</font>) <a href=\"https://seekingalpha.com/pr/17262031-descartes-reports-fiscal-2019-second-quarter-financial-results\" target=\"_blank\">reports Q2</a>&nbsp;revenue growth of 17.1% Y/Y to $67.1M.</li><li>Services revenues were up 21% Y/Y to $59.7M.</li><li>Cash provided by operating activities of $18.2M up 6% Y/Y.</li><li>Gross margin&nbsp;<font color='green'>increased 100 bps</font>&nbsp;Q/Q to 73% Adj. EBITDA&nbsp;<font color='red'>declined 100 bps&nbsp;</font>Y/Y to 34%.</li><li>Descartes had $34.1M in cash, decrease was due to credit facility repayments partially offset by cash provided from operations.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388115-descartes-systems-beats-0_01-misses-revenue\" target=\"_blank\">Descartes Systems beats by $0.01, misses on revenue</a> (Sept. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388381\" data-linked=\"Descartes Systems down 2.5% post Q2 results\" data-tweet=\"$DSGX - Descartes Systems down 2.5% post Q2 results https://seekingalpha.com/news/3388381-descartes-systems-down-2_5-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3388381-descartes-systems-down-2_5-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388375\" data-ts=\"1536244528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388375-selling-pressure-on-macau-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selling pressure on Macau stocks</a></h4><ul> <li>Macau stocks are spinning lower after a soft overall market day in Hong Kong and a sudden downturn in sentiment on the sector.</li><li>The selling pressure arrives a few days after a report on August GGR that looked positive to most analysts.</li> <li>Decliners in the U.S. include Melco Resorts &amp; Entertainment (<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a> <font color='red'>-8.4%</font>), Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='red'>-6.1%</font>), Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='red'>-2.5%</font>) and MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='red'>-2%</font>).</li> <li>Wynn Resorts hit a 52-week low with a swing to $131.19.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3388375\" data-linked=\"Selling pressure on Macau stocks\" data-tweet=\"$MLCO $MLCO $WYNN - Selling pressure on Macau stocks https://seekingalpha.com/news/3388375-selling-pressure-on-macau-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3388375-selling-pressure-on-macau-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388373\" data-ts=\"1536244220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388373-eia-natural-gas-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Natural Gas Inventory</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+63 Bcf</strong> vs. +62 Bcf consensus, +70 Bcf last week.</li><li>Futures&nbsp;<font color='red'>-0.43%</font>&nbsp;to $2.783.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3388373\" data-linked=\"EIA Natural Gas Inventory\" data-tweet=\"$UNG $DGAZ $UGAZ - EIA Natural Gas Inventory https://seekingalpha.com/news/3388373-eia-natural-gas-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3388373-eia-natural-gas-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388370\" data-ts=\"1536243992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DEST\" target=\"_blank\">DEST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388370-destination-maternity-breaks-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Destination Maternity breaks higher</a></h4><ul> <li>Shares of Destination Maternity (NASDAQ:<a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a>) are&nbsp;<font color='green'>up 3.6%</font>&nbsp;in early trading.</li> <li>Last week, the retailer disclosed that it entered into an agreement with shareholder Nathan Miller to share information as it looks to maximize long-term value for investors.</li> <li>Destination Maternity is due to report FQ2 earnings on September 10.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3388370\" data-linked=\"Destination Maternity breaks higher\" data-tweet=\"$DEST - Destination Maternity breaks higher https://seekingalpha.com/news/3388370-destination-maternity-breaks-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3388370-destination-maternity-breaks-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388368\" data-ts=\"1536243929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REVG\" target=\"_blank\">REVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388368-rev-group-slips-17-post-q3-results-miss-reduced-fy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REV Group slips 17% post Q3 results miss, reduced FY guidance</a></h4><ul><li>REV Group (<a href='https://seekingalpha.com/symbol/REVG' title='REV Group'>REVG</a> <font color='red'>-17.1%</font>) reported Q3 net sales of $597.7M an increase of 0.4% Y/Y. Company continues to be impacted by chassis and material availability issues.</li><li>Segment sales: Fire &amp; Emergency $238.9M (-8.9% Y/Y); Commercial $157.6M (+2.1% Y/Y) and Recreation $197.3M (+10.9% Y/Y).</li><li>Q3 Overall margins: Gross&nbsp;<font color='green'>improved by 20 bps&nbsp;</font>to 13.3% and operating was flat at 4.8%.</li><li>Adj. EBITDA increased by 4.6% Y/Y to $47.6M and margin&nbsp;<font color='green'>improved by 40 bps&nbsp;</font>to 8%.</li><li>Total backlog was at $1.28B (+34.1% Y/Y). Backlog by segment: Fire &amp; Emergency $606.5M (+4.5% Y/Y); Commercial $420M (+64.8% Y/Y) and Recreation $249.5M (+114.9% Y/Y).</li><li>Cash and equivalents were $14.7M as of July 31, 2018 and Net debt was $427M.</li><li>Company repurchased ~2.5M shares for $40.7M under its share repurchase authorization during Q3. The Board has authorized an additional $50M share repurchase program.</li><li><strong>FY18 Guidance:</strong> Revenue $2.4-2.5B, net income $57.9-69M; Adj. EBITDA $160-170M and Adj. net income $80.7-88.8M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388127-rev-group-misses-0_06-misses-revenue\" target=\"_blank\">REV Group misses by $0.06, misses on revenue</a> (Sept. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388368\" data-linked=\"REV Group slips 17% post Q3 results miss, reduced FY guidance\" data-tweet=\"$REVG - REV Group slips 17% post Q3 results miss, reduced FY guidance https://seekingalpha.com/news/3388368-rev-group-slips-17-post-q3-results-miss-reduced-fy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3388368-rev-group-slips-17-post-q3-results-miss-reduced-fy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388366\" data-ts=\"1536243271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JP\" target=\"_blank\">JP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388366-jupai-slumps-after-q2-reflects-conservative-investing-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jupai slumps after Q2 reflects more conservative investing in China</a></h4><ul><li>Jupai Holdings (<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='red'>-7.7%</font>) sinks after the Chinese third-party wealth management service provider<a href=\"https://seekingalpha.com/pr/17262334-jupai-reports-second-quarter-2018-results\" target=\"_blank\"> posts Q2 </a>net income per ADS RMB2.63 (US$0.38) vs. RMB3.33 a year earlier as tighter financial regulations in China pushed investors to be more conservative.</li><li>Q2 non-GAAP net income per ADS RMB3.28 (US$0.50) vs. RMB3.72 a year ago.</li><li>\"Over the past quarter, we have seen stronger headwinds in&nbsp;China's&nbsp;wealth management industry, as investors become increasingly conservative in the face of the government's accelerated deleveraging at the macro-economic level and tightened regulations in the financial services sector,\" said Mr.&nbsp;Jianda Ni, Jupai's chairman of the board and chief executive officer.</li><li>Q2 operating margin 36.1% vs. 38.0% a year ago.</li><li>Net margin attributable to ordinary shareholders 18.8% vs. 25.8% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388228-jupai-holdings-reports-q2-results\" target=\"_blank\">Jupai Holdings reports Q2 results</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388366\" data-linked=\"Jupai slumps after Q2 reflects more conservative investing in China\" data-tweet=\"$JP - Jupai slumps after Q2 reflects more conservative investing in China https://seekingalpha.com/news/3388366-jupai-slumps-after-q2-reflects-conservative-investing-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3388366-jupai-slumps-after-q2-reflects-conservative-investing-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388364\" data-ts=\"1536243128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388364-infineraminus-7_1-amid-275m-convertible-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera -7.1% amid $275M convertible note offering</a></h4><ul>   <li>Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) has <font color='red'>slid 7.1%</font> and nearly surpassed average daily volume after its announcement of a <a href=\"https://seekingalpha.com/pr/17262077-infinera-corporation-announces-proposed-275-million-convertible-senior-notes-offering\" target=\"_blank\">$275M offering of convertible notes</a>.</li>    <li>The company will offer that amount in senior notes due 2024.</li>    <li>Underwriters will get a 30-day option to buy up to an additional $41.25M in notes to cover overallotment.</li>    <li>The notes will be convertible into cash, stock or some combination; prior to June 1, 2024, they'll be convertible at holders' option on certain conditions during certain periods.</li>    <li>Part of the net proceeds will fund the company's Coriant acquisition, and some will pay the cost of capped call transactions designed to offset dilution from note conversion.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388364\" data-linked=\"Infinera -7.1% amid $275M convertible note offering\" data-tweet=\"$INFN - Infinera -7.1% amid $275M convertible note offering https://seekingalpha.com/news/3388364-infineraminus-7_1-amid-275m-convertible-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3388364-infineraminus-7_1-amid-275m-convertible-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388363\" data-ts=\"1536243083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CKPT\" target=\"_blank\">CKPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388363-checkpoints-ckminus-101-shows-positive-action-in-lung-cancer-study-investors-unmoved-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Checkpoint&#39;s CK-101 shows positive action in lung cancer study; investors unmoved, shares down 4%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17262466-checkpoint-therapeutics-announces-encouraging-safety-efficacy-data-phase-1-2-clinical-trial\" target=\"_blank\">Preliminary data</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02926768?term=NCT02926768&amp;rank=1\" target=\"_blank\">Phase 1/2 clinical trial </a>evaluating Checkpoint Therapeutics' (<a href='https://seekingalpha.com/symbol/CKPT' title='CHECKPOINT THERAPEUTICS'>CKPT</a> <font color='red'>-3.8%</font>) CK-101, a third-generation epidermal growth factor receptor &#40;EGFR&#41; tyrosine kinase inhibitor &#40;TKI&#41;, in patients with advanced non-small cell lung cancer &#40;NSCLC&#41; showed a treatment effect. The results will be presented at the World Conference on Lung Cancer in Toronto on Monday, September 24.</li><li>75% (n=6/8) of treatment-naive patients experienced partial responses. 50% (n=3/6) of patients with brain metastases at baseline experienced partial responses. The disease control rate (responders + those with stable cancer) was 100% (n=19/19). 84% (n=16/19) showed target lesion reduction from baseline.</li><li>No dose-limiting toxicities or serious treatment-related serious adverse events were reported. The most common treatment-related adverse events were nausea (16%), diarrhea (14%), increased lacrimation (flow of tears) (14%) and vomiting (11%).</li><li>Enrollment is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388363\" data-linked=\"Checkpoint&#39;s CK-101 shows positive action in lung cancer study; investors unmoved, shares down 4%\" data-tweet=\"$CKPT - Checkpoint&#39;s CK-101 shows positive action in lung cancer study; investors unmoved, shares down 4% https://seekingalpha.com/news/3388363-checkpoints-ckminus-101-shows-positive-action-in-lung-cancer-study-investors-unmoved-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3388363-checkpoints-ckminus-101-shows-positive-action-in-lung-cancer-study-investors-unmoved-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388355\" data-ts=\"1536241861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUN\" target=\"_blank\">FUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388355-cedar-fair-rallies-after-record-august\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cedar Fair rallies after record August</a></h4><ul> <li>Cedar Fair (<a href='https://seekingalpha.com/symbol/FUN' title='Cedar Fair, L.P.'>FUN</a> <font color='green'>+2.3%</font>) announces record revenue for August on a preliminary look at results.</li><li>The company says preliminary revenue was up 6% Y/Y to $288M on a 5% increase in traffic.</li><li>Average in-park per capita spending was up 1% during the month and out-of-park revenue rose&nbsp; 7%.</li> <li>\"Over the past five weeks we have experienced strong growth across all aspects of our business, reaffirming our confidence in the resiliency of our business model and the outlook for growth in the business for the long term,\" says Cedar Fair CEO&nbsp;Richard Zimmerman.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17262281-cedar-fair-reports-record-revenues-august\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388355\" data-linked=\"Cedar Fair rallies after record August\" data-tweet=\"$FUN - Cedar Fair rallies after record August https://seekingalpha.com/news/3388355-cedar-fair-rallies-after-record-august?source=tweet\" data-url=\"https://seekingalpha.com/news/3388355-cedar-fair-rallies-after-record-august\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388351\" data-ts=\"1536241686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388351-merrimack-pharma-completes-enrollment-in-mid-stage-study-of-mmminus-121-in-certain-type-of\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack Pharma completes enrollment in mid-stage study of MM-121 in certain type of lung cancer; shares down 2%</a></h4><ul><li>Thinly traded nano cap Merrimack Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-1.9%</font>) is down in early trade, albeit on only 2,700 shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17262379-merrimack-completes-enrollment-randomized-phase-2-sherloc-study-mmminus-121-seribantumab-non\" target=\"_blank\">announcement </a>that its Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02387216?lead=merrimack&amp;phase=1&amp;rank=3\" target=\"_blank\">SHERLOC</a>, evaluating MM-121 (seribantumab) in patients with heregulin-positive non-small cell lung cancer &#40;NSCLC&#41; is now fully enrolled.</li><li>The open-label study will assess MM-121 + docetaxel compared to docetaxel alone. The primary endpoint is progression-free survival &#40;PFS&#41;. According to ClinicalTrials.gov, the estimated completion date is December.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388351\" data-linked=\"Merrimack Pharma completes enrollment in mid-stage study of MM-121 in certain type of lung cancer; shares down 2%\" data-tweet=\"$MACK - Merrimack Pharma completes enrollment in mid-stage study of MM-121 in certain type of lung cancer; shares down 2% https://seekingalpha.com/news/3388351-merrimack-pharma-completes-enrollment-in-mid-stage-study-of-mmminus-121-in-certain-type-of?source=tweet\" data-url=\"https://seekingalpha.com/news/3388351-merrimack-pharma-completes-enrollment-in-mid-stage-study-of-mmminus-121-in-certain-type-of\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388353\" data-ts=\"1536241647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388353-amdminus-1_8-after-arete-downgrades-to-best-short-idea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD -1.8% after Arete downgrades to Best Short Idea</a></h4><ul><li>        Arete <a href=\"https://thefly.com/landingPageNews.php?id=2786720&amp;headline=AMD;INTC-AMD-Intel-rating-change-\" target=\"_blank\">downgrades</a> AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) from Negative to a Best Idea Short, sending shares&nbsp;<font color='red'>down 1.8%</font>&nbsp;to $28. &nbsp;&nbsp;</li><li>        Arete says the &ldquo;debate is raging&rdquo; over how the server fight between AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) and Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+0.3%</font>) will end and says the &ldquo;extreme views taking root &hellip; look far-fetched.&rdquo;</li><li>                  The firm says investors expecting AMD EPS of $2+ will face disappointment.&nbsp;&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3388353\" data-linked=\"AMD -1.8% after Arete downgrades to Best Short Idea\" data-tweet=\"$AMD $AMD $INTC - AMD -1.8% after Arete downgrades to Best Short Idea https://seekingalpha.com/news/3388353-amdminus-1_8-after-arete-downgrades-to-best-short-idea?source=tweet\" data-url=\"https://seekingalpha.com/news/3388353-amdminus-1_8-after-arete-downgrades-to-best-short-idea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>216&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388350\" data-ts=\"1536241579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388350-nikes-12-city-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike&#39;s 12-city strategy</a></h4><ul> <li>Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+0.3%</font>) knows what it's doing, according to marketing experts and Wall Street analysts.</li> <li>On a business level, the company's \"Consumer Direct Offense\" mapped out in 2017 targeted 12 key cities (New York, London, Shanghai, Beijing, Los Angeles, Tokyo, Paris, Berlin, Mexico City, Barcelona, Seoul, and Milan) which it forecast would be responsible for <a href=\"https://www.forbes.com/sites/prishe/2018/09/06/nikes-reward-using-kaepernick-exceeds-risk-due-to-knowing-their-demo-and-being-culturally-relevant/#b1fef45672a7\" target=\"_blank\">80%</a> of the Swoosh's growth through 2020. Further research indicated that the younger generations with the greatest future purchasing power value brand relevancy. Connecting the dots, Nike needed a brand <a href=\"https://www.wsj.com/articles/colin-kaepernick-and-nike-starring-you-and-me-1536177307\" target=\"_blank\">reboot</a> after the recent #MeToo allegations at the company set it back with the younger consumers spending the most on the company's array of products.</li> <li>On Wall Street, no major firms have downgraded Nike and analysts have pointed to a long string of companies that navigated around short-term political backlash with share prices intact.</li> <li>Shares of Nike are <font color='red'>down 2.4%</font> for the week, but investors could get a crack at an even lower entry point if the first Colin Kaepernick advertisement (airs tonight during the NFL opener) inflames some selling pressure again. On a YTD look, Nike is up 27%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388350\" data-linked=\"Nike&#39;s 12-city strategy\" data-tweet=\"$NKE - Nike&#39;s 12-city strategy https://seekingalpha.com/news/3388350-nikes-12-city-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3388350-nikes-12-city-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}